| Year |
Citation |
Score |
| 2024 |
Stern S, Zhang L, Wang M, Wright R, Rosh I, Hussein Y, Stern T, Choudhary A, Tripathi U, Reed P, Sadis H, Nayak R, Shemen A, Agarwal K, Cordeiro D, ... ... Kahn RS, et al. Monozygotic twins discordant for schizophrenia differ in maturation and synaptic transmission. Molecular Psychiatry. PMID 38704507 DOI: 10.1038/s41380-024-02561-1 |
0.304 |
|
| 2024 |
González-Peñas J, Alloza C, Brouwer R, Díaz-Caneja CM, Costas J, González-Lois N, Gallego AG, de Hoyos L, Gurriarán X, Andreu-Bernabeu Á, Romero-García R, Fañanas L, Bobes J, Pinto AG, Crespo-Facorro B, ... ... Kahn RS, et al. Accelerated Cortical Thinning in Schizophrenia is Associated With Rare and Common Predisposing Variation to Schizophrenia and Neurodevelopmental Disorders. Biological Psychiatry. PMID 38521159 DOI: 10.1016/j.biopsych.2024.03.011 |
0.307 |
|
| 2024 |
Wannan CMJ, Nelson B, Addington J, Allott K, Anticevic A, Arango C, Baker JT, Bearden CE, Billah T, Bouix S, Broome MR, Buccilli K, Cadenhead KS, Calkins ME, Cannon TD, ... ... Kahn RS, et al. Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis. Schizophrenia Bulletin. PMID 38451304 DOI: 10.1093/schbul/sbae011 |
0.428 |
|
| 2023 |
Ge R, Yu Y, Qi YX, Fan YV, Chen S, Gao C, Haas SS, Modabbernia A, New F, Agartz I, Asherson P, Ayesa-Arriola R, Banaj N, Banaschewski T, Baumeister S, ... ... Kahn RS, et al. Normative Modeling of Brain Morphometry Across the Lifespan Using CentileBrain: Algorithm Benchmarking and Model Optimization. Biorxiv : the Preprint Server For Biology. PMID 38076938 DOI: 10.1101/2023.01.30.523509 |
0.527 |
|
| 2023 |
Schijven D, Postema MC, Fukunaga M, Matsumoto J, Miura K, de Zwarte SMC, van Haren NEM, Cahn W, Hulshoff Pol HE, Kahn RS, Ayesa-Arriola R, Ortiz-García de la Foz V, Tordesillas-Gutierrez D, Vázquez-Bourgon J, Crespo-Facorro B, et al. Large-scale analysis of structural brain asymmetries in schizophrenia via the ENIGMA consortium. Proceedings of the National Academy of Sciences of the United States of America. 120: e2213880120. PMID 36976765 DOI: 10.1073/pnas.2213880120 |
0.311 |
|
| 2023 |
Haas SS, Ge R, Agartz I, Amminger GP, Andreassen OA, Bachman P, Baeza I, Choi S, Colibazzi T, Cropley VL, de la Fuente-Sandoval C, Ebdrup BH, Fortea A, Fusar-Poli P, Glenthøj BY, ... ... Kahn RS, et al. Normative modeling of brain morphometry in Clinical High-Risk for Psychosis. Biorxiv : the Preprint Server For Biology. PMID 36711551 DOI: 10.1101/2023.01.17.523348 |
0.551 |
|
| 2022 |
Demjaha A, Galderisi S, Glenthøj B, Arango C, Mucci A, Lawrence A, O'Daly O, Kempton M, Ciufolini S, Baandrup L, Ebdrup BH, Rodriguez-Jimenez R, Diaz-Marsa M, Díaz-Caneja CM, Winter van Rossum I, ... Kahn R, et al. Negative symptoms in First-Episode Schizophrenia related to morphometric alterations in orbitofrontal and superior temporal cortex: the OPTiMiSE study. Psychological Medicine. 1-9. PMID 35197142 DOI: 10.1017/S0033291722000010 |
0.32 |
|
| 2021 |
Vissink CE, Winter-van Rossum I, Cannon TD, Fusar-Poli P, Kahn RS, Bossong MG. Structural Brain Volumes of Individuals at Clinical High Risk for Psychosis: A Meta-analysis. Biological Psychiatry Global Open Science. 2: 147-152. PMID 36325161 DOI: 10.1016/j.bpsgos.2021.09.002 |
0.388 |
|
| 2021 |
Lehet M, Tso IF, Park S, Neggers SFW, Thompson IA, Kahn RS, Thakkar KN. Altered Effective Connectivity within an Oculomotor Control Network in Unaffected Relatives of Individuals with Schizophrenia. Brain Sciences. 11. PMID 34573248 DOI: 10.3390/brainsci11091228 |
0.325 |
|
| 2020 |
Dazzan P, Lawrence AJ, Reinders AATS, Egerton A, van Haren NEM, Merritt K, Barker GJ, Perez-Iglesias R, Sendt KV, Demjaha A, Nam KW, Sommer IE, Pantelis C, Wolfgang Fleischhacker W, van Rossum IW, ... ... Kahn RS, et al. Symptom Remission and Brain Cortical Networks at First Clinical Presentation of Psychosis: The OPTiMiSE Study. Schizophrenia Bulletin. PMID 33057670 DOI: 10.1093/schbul/sbaa115 |
0.307 |
|
| 2020 |
de Zwarte SMC, Brouwer RM, Agartz I, Alda M, Alonso-Lana S, Bearden CE, Bertolino A, Bonvino A, Bramon E, Buimer EEL, Cahn W, Canales-Rodríguez EJ, Cannon DM, Cannon TD, Caseras X, ... ... Kahn RS, et al. Intelligence, educational attainment, and brain structure in those at familial high-risk for schizophrenia or bipolar disorder. Human Brain Mapping. PMID 33027543 DOI: 10.1002/hbm.25206 |
0.518 |
|
| 2020 |
Janssen J, Díaz-Caneja CM, Alloza C, Schippers A, de Hoyos L, Santonja J, Gordaliza PM, Buimer EEL, van Haren NEM, Cahn W, Arango C, Kahn RS, Hulshoff Pol HE, Schnack HG. Dissimilarity in Sulcal Width Patterns in the Cortex can be Used to Identify Patients With Schizophrenia With Extreme Deficits in Cognitive Performance. Schizophrenia Bulletin. PMID 32964935 DOI: 10.1093/schbul/sbaa131 |
0.342 |
|
| 2020 |
Yao B, Neggers SFW, Kahn RS, Thakkar KN. Altered thalamocortical structural connectivity in persons with schizophrenia and healthy siblings. Neuroimage. Clinical. 28: 102370. PMID 32798913 DOI: 10.1016/j.nicl.2020.102370 |
0.328 |
|
| 2020 |
Ormel PR, Böttcher C, Gigase FAJ, Missall RD, van Zuiden W, Fernández Zapata MC, Ilhan D, de Goeij M, Udine E, Sommer IEC, Priller J, Raj T, Kahn RS, Hol EM, de Witte LD. A characterization of the molecular phenotype and inflammatory response of schizophrenia patient-derived microglia-like cells. Brain, Behavior, and Immunity. PMID 32798663 DOI: 10.1016/J.Bbi.2020.08.012 |
0.406 |
|
| 2020 |
Correll CU, Newcomer JW, Silverman B, DiPetrillo L, Graham C, Jiang Y, Du Y, Simmons A, Hopkinson C, McDonnell D, Kahn RS. Effects of Olanzapine Combined With Samidorphan on Weight Gain in Schizophrenia: A 24-Week Phase 3 Study. The American Journal of Psychiatry. appiajp202019121279. PMID 32791894 DOI: 10.1176/Appi.Ajp.2020.19121279 |
0.383 |
|
| 2020 |
Thygesen JH, Presman A, Harju-Seppänen J, Irizar H, Jones R, Kuchenbaecker K, Lin K, Alizadeh BZ, Austin-Zimmerman I, Bartels-Velthuis A, Bhat A, Bruggeman R, Cahn W, Calafato S, Crespo-Facorro B, ... ... Kahn R, et al. Genetic copy number variants, cognition and psychosis: a meta-analysis and a family study. Molecular Psychiatry. PMID 32719466 DOI: 10.1038/S41380-020-0820-7 |
0.402 |
|
| 2020 |
Fountoulakis KN, Moeller HJ, Kasper S, Tamminga C, Yamawaki S, Kahn R, Tandon R, Correll CU, Javed A. The report of the joint WPA/CINP workgroup on the use and usefulness of antipsychotic medication in the treatment of schizophrenia. Cns Spectrums. 1-75. PMID 32594935 DOI: 10.1017/S1092852920001546 |
0.339 |
|
| 2020 |
Troudet R, Ali WBH, Bacq-Daian D, Rossum IWV, Boland-Auge A, Battail C, Barau C, Rujescu D, McGuire P, Kahn RS, Deleuze JF, Leboyer M, Jamain S. Gene expression and response prediction to amisulpride in the OPTiMiSE first episode psychoses. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 32450569 DOI: 10.1038/S41386-020-0703-2 |
0.32 |
|
| 2020 |
Baandrup L, Allerup P, Nielsen MØ, Bak N, Düring SW, Leucht S, Galderisi S, Mucci A, Bucci P, Arango C, Díaz-Caneja CM, Dazzan P, McGuire P, Demjaha A, Ebdrup BH, ... Kahn RS, et al. Rasch analysis of the PANSS negative subscale and exploration of negative symptom trajectories in first-episode schizophrenia - data from the OPTiMiSE trial. Psychiatry Research. 289: 112970. PMID 32438207 DOI: 10.1016/J.Psychres.2020.112970 |
0.336 |
|
| 2020 |
Correll CU, Newcomer JW, Silverman B, DiPetrillo L, Graham C, Jiang Y, Du Y, Simmons A, Hopkinson C, McDonnell D, Kahn R. 100 Olanzapine/Samidorphan for Schizophrenia: Weight Gain and Metabolic Outcomes in Phase 3 ENLIGHTEN-2 and Subsequent Long-Term, Open-Label Safety Study. Cns Spectrums. 25: 265. PMID 32331090 DOI: 10.1017/S1092852920000188 |
0.309 |
|
| 2020 |
Boks MP, He Y, Schubart CD, van Gastel W, Elkrief L, Huguet G, van Eijk K, Vinkers CH, Kahn RS, Paus T, Conrod P, Hol EM, de Witte LD. Cannabinoids and psychotic symptoms: A potential role for a genetic variant in the P2X purinoceptor 7 (P2RX7) gene. Brain, Behavior, and Immunity. PMID 32330591 DOI: 10.1016/J.Bbi.2020.04.051 |
0.304 |
|
| 2020 |
Bucci P, Mucci A, van Rossum IW, Aiello C, Arango C, Baandrup L, Buchanan RW, Dazzan P, Demjaha A, Díaz-Caneja CM, Giordano GM, Glenthøj BY, Leucht S, McGuire P, Rodriguez-Jimenez R, ... ... Kahn RS, et al. Persistent negative symptoms in recent-onset psychosis: Relationship to treatment response and psychosocial functioning. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 32291210 DOI: 10.1016/J.Euroneuro.2020.03.010 |
0.349 |
|
| 2020 |
Kahn RS. On the Origins of Schizophrenia. The American Journal of Psychiatry. 177: 291-297. PMID 32233682 DOI: 10.1176/Appi.Ajp.2020.20020147 |
0.416 |
|
| 2020 |
Higgins-Chen AT, Boks MP, Vinkers CH, Kahn RS, Levine ME. Schizophrenia and Epigenetic Aging Biomarkers: Increased Mortality, Reduced Cancer Risk, and Unique Clozapine Effects. Biological Psychiatry. PMID 32199607 DOI: 10.1016/J.Biopsych.2020.01.025 |
0.318 |
|
| 2020 |
Grasby KL, Jahanshad N, Painter JN, Colodro-Conde L, Bralten J, Hibar DP, Lind PA, Pizzagalli F, Ching CRK, McMahon MAB, Shatokhina N, Zsembik LCP, Thomopoulos SI, Zhu AH, Strike LT, ... ... Kahn RS, et al. The genetic architecture of the human cerebral cortex. Science (New York, N.Y.). 367. PMID 32193296 DOI: 10.1126/Science.Aay6690 |
0.541 |
|
| 2020 |
Chand GB, Dwyer DB, Erus G, Sotiras A, Varol E, Srinivasan D, Doshi J, Pomponio R, Pigoni A, Dazzan P, Kahn RS, Schnack HG, Zanetti MV, Meisenzahl E, Busatto GF, et al. Two distinct neuroanatomical subtypes of schizophrenia revealed using machine learning. Brain : a Journal of Neurology. PMID 32103250 DOI: 10.1093/Brain/Awaa025 |
0.368 |
|
| 2020 |
van Haren NEM, Setiaman N, Koevoets MGJC, Baalbergen H, Kahn RS, Hillegers MHJ. Brain structure, IQ, and psychopathology in young offspring of patients with schizophrenia or bipolar disorder. European Psychiatry : the Journal of the Association of European Psychiatrists. 63: e5. PMID 32093799 DOI: 10.1192/J.Eurpsy.2019.19 |
0.443 |
|
| 2020 |
Okhuijsen-Pfeifer C, Sterk AY, Horn IM, Terstappen J, Kahn RS, Luykx JJ. Demographic and clinical features as predictors of clozapine response in patients with schizophrenia spectrum disorders: a systematic review and meta-analysis. Neuroscience and Biobehavioral Reviews. PMID 31982601 DOI: 10.1016/J.Neubiorev.2020.01.017 |
0.384 |
|
| 2020 |
van Leeuwen JMC, Vinkers CH, Vink M, Kahn RS, Joëls M, Hermans EJ. Disrupted upregulation of salience network connectivity during acute stress in siblings of schizophrenia patients. Psychological Medicine. 1-11. PMID 31941558 DOI: 10.1017/S0033291719004033 |
0.733 |
|
| 2020 |
Renkema TC, Haan Ld, Schirmbeck F, Alizadeh BZ, Amelsvoort Tv, Bartels-Velthuis AA, Beveren NJv, Bruggeman R, Cahn W, Delespaul P, Luykx JJ, Myin-Germeys I, Kahn RS, Simons CJP, Os Jv, et al. Childhood trauma and coping in patients with psychotic disorders and obsessive-compulsive symptoms and in un-affected siblings. Child Abuse & Neglect. 99: 104243. PMID 31783309 DOI: 10.1016/J.Chiabu.2019.104243 |
0.304 |
|
| 2020 |
Zwarte SMCd, Brouwer RRM, Kahn RS, Turner JA, Erp TGMv, Andreasen OA, Ching CRK, Jahanshad N, Thompson PM, Haren NV, Relatives E. M166. The Effect Of Intelligence And Educational Attainment On The Brain In Those With Familial High Risk For Schizophrenia Or Bipolar Disorder: An Enigma–Relatives Study Schizophrenia Bulletin. 46. DOI: 10.1093/Schbul/Sbaa030.478 |
0.364 |
|
| 2020 |
Pina-Camacho L, Diaz-Caneja CM, Fraguas D, Boada L, Parellada M, Winter-van Rossum I, Kahn R, Arango C. T117. PROMINENT AND PERSISTENT AUTISTIC TRAITS ARE ASSOCIATED WITH EARLY NON-REMISSION IN FIRST-EPISODE SCHIZOPHRENIA Schizophrenia Bulletin. 46: S275-S275. DOI: 10.1093/Schbul/Sbaa029.677 |
0.414 |
|
| 2020 |
Lyliana N, Winter I, Kahn R, Sommer I. T43. PREDNISOLONE VERSUS PLACEBO AS AUGMENTATION THERAPY IN PSYCHOTIC DISORDERS Schizophrenia Bulletin. 46: S248-S248. DOI: 10.1093/Schbul/Sbaa029.603 |
0.32 |
|
| 2020 |
Lehet M, Yao B, Tso IF, Kahn RS, Neggers SF, Thakkar KN. Compromised Neural Circuit Dynamics Underlying Impaired Control of Eye Movements in Schizophrenia Biological Psychiatry. 87: S375-S376. DOI: 10.1016/J.Biopsych.2020.02.961 |
0.345 |
|
| 2020 |
Chand G, Wolf DH, Erus G, Srinivasan D, Dwyer DB, Pomponio R, Sotiras A, Varol E, Doshi J, Pigoni A, Dazzan P, Kahn RS, Schnack HG, Zanetti MV, Meisenzahl E, et al. Neuroanatomical Dimensional Phenotypes of Schizophrenia: Expression in Youth With Psychosis-Spectrum Symptoms and Correlation With Cognition Biological Psychiatry. 87: S119. DOI: 10.1016/J.Biopsych.2020.02.324 |
0.36 |
|
| 2020 |
van Leeuwen J, Vinkers C, Vink M, Kahn R, Joels M, Hermans E. Neural Temporal Dynamics of Stress in At-Risk Individuals Biological Psychiatry. 87: S89-S90. DOI: 10.1016/J.Biopsych.2020.02.250 |
0.607 |
|
| 2020 |
Wolf D, Chand G, Dwyer D, Erus G, Sotiras A, Varol E, Srinivasan D, Doshi J, Pomponio R, Pigoni A, Dazzan P, Kahn RS, Schnack HG, Zanetti MV, Meisenzahl E, et al. Two Neuroanatomical Subtypes of Schizophrenia Defined by Multi-Site Machine Learning Biological Psychiatry. 87: S28-S29. DOI: 10.1016/J.Biopsych.2020.02.097 |
0.319 |
|
| 2019 |
Lam M, Chen CY, Li Z, Martin AR, Bryois J, Ma X, Gaspar H, Ikeda M, Benyamin B, Brown BC, Liu R, Zhou W, Guan L, Kamatani Y, Kim SW, ... ... Kahn RS, et al. Comparative genetic architectures of schizophrenia in East Asian and European populations. Nature Genetics. PMID 31740837 DOI: 10.1038/S41588-019-0512-X |
0.393 |
|
| 2019 |
Sneeboer MAM, van der Doef T, Litjens M, Psy NBB, Melief J, Hol EM, Kahn RS, de Witte LD. Microglial activation in schizophrenia: Is translocator 18 kDa protein (TSPO) the right marker? Schizophrenia Research. PMID 31699629 DOI: 10.1016/J.Schres.2019.10.045 |
0.415 |
|
| 2019 |
Turk E, van den Heuvel MI, Benders MJ, de Heus R, Franx A, Manning JH, Hect JL, Hernandez-Andrade E, Hassan SS, Romero R, Kahn RS, Thomason ME, van den Heuvel MP. Functional connectome of the fetal brain. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 31685648 DOI: 10.1523/Jneurosci.2891-18.2019 |
0.302 |
|
| 2019 |
Sneeboer MAM, van Mierlo HC, Stotijn E, MacIntyre DJ, Smith C, Kahn RS, Hol EM, de Witte LD. Increased number of T-lymphocytes in post-mortem brain tissue of patients with schizophrenia. Schizophrenia Research. PMID 31676171 DOI: 10.1016/J.Schres.2019.10.032 |
0.394 |
|
| 2019 |
Satizabal CL, Adams HHH, Hibar DP, White CC, Knol MJ, Stein JL, Scholz M, Sargurupremraj M, Jahanshad N, Roshchupkin GV, Smith AV, Bis JC, Jian X, Luciano M, Hofer E, ... ... Kahn RS, et al. Genetic architecture of subcortical brain structures in 38,851 individuals. Nature Genetics. PMID 31636452 DOI: 10.1038/S41588-019-0511-Y |
0.537 |
|
| 2019 |
Kahn RS. On the Specificity of Continuous Cognitive Decline in Schizophrenia. The American Journal of Psychiatry. 176: 774-776. PMID 31569987 DOI: 10.1176/Appi.Ajp.2019.19080794 |
0.378 |
|
| 2019 |
van Leeuwen JMC, Vink M, Joëls M, Kahn RS, Hermans EJ, Vinkers CH. Reward-Related Striatal Responses Following Stress in Healthy Individuals and Patients With Bipolar Disorder. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 31471186 DOI: 10.1016/J.Bpsc.2019.06.014 |
0.727 |
|
| 2019 |
de Zwarte SMC, Brouwer RM, Agartz I, Alda M, Aleman A, Alpert KI, Bearden CE, Bertolino A, Bois C, Bonvino A, Bramon E, Buimer EEL, Cahn W, Cannon DM, Cannon TD, ... ... Kahn RS, et al. The Association Between Familial Risk and Brain Abnormalities Is Disease Specific: An ENIGMA-Relatives Study of Schizophrenia and Bipolar Disorder. Biological Psychiatry. PMID 31443932 DOI: 10.1016/J.Biopsych.2019.03.985 |
0.593 |
|
| 2019 |
de Lange SC, Scholtens LH, van den Berg LH, Boks MP, Bozzali M, Cahn W, Dannlowski U, Durston S, Geuze E, van Haren NEM, Hillegers MHJ, Koch K, Jurado MÁ, Mancini M, ... ... Kahn RS, et al. Shared vulnerability for connectome alterations across psychiatric and neurological brain disorders. Nature Human Behaviour. PMID 31384023 DOI: 10.1038/S41562-019-0659-6 |
0.322 |
|
| 2019 |
Pandit R, Cianci D, Ter Hark SE, Winter-van Rossum I, Ebdrup BH, Broberg BV, Garcia-Portilla MP, Bobes J, Vinkers CH, Kahn RS, Guloksuz S, Huitema ADR, Luykx JJ. Phenotypic factors associated with amisulpride-induced weight gain in first-episode psychosis patients (from the OPTIMISE cohort). Acta Psychiatrica Scandinavica. PMID 31323113 DOI: 10.1111/Acps.13074 |
0.312 |
|
| 2019 |
van den Heuvel MP, Scholtens LH, Kahn RS. Multiscale Neuroscience of Psychiatric Disorders. Biological Psychiatry. PMID 31320130 DOI: 10.1016/J.Biopsych.2019.05.015 |
0.304 |
|
| 2019 |
van Mierlo HC, Broen JCA, Kahn RS, de Witte LD. B-cells and schizophrenia: A promising link or a finding lost in translation? Brain, Behavior, and Immunity. PMID 31271869 DOI: 10.1016/J.Bbi.2019.06.043 |
0.372 |
|
| 2019 |
Berdenis van Berlekom A, Muflihah CH, Snijders GJLJ, MacGillavry HD, Middeldorp J, Hol EM, Kahn RS, de Witte LD. Synapse Pathology in Schizophrenia: A Meta-analysis of Postsynaptic Elements in Postmortem Brain Studies. Schizophrenia Bulletin. PMID 31192350 DOI: 10.1093/Schbul/Sbz060 |
0.331 |
|
| 2019 |
Sneeboer MAM, Snijders GJLJ, Berdowski WM, Fernández-Andreu A, van Mierlo HC, Berdenis van Berlekom A, Litjens M, Kahn RS, Hol EM, de Witte LD. Microglia in post-mortem brain tissue of patients with bipolar disorder are not immune activated. Translational Psychiatry. 9: 153. PMID 31127084 DOI: 10.1038/S41398-019-0490-X |
0.303 |
|
| 2019 |
Stahl EA, Breen G, Forstner AJ, McQuillin A, Ripke S, Trubetskoy V, Mattheisen M, Wang Y, Coleman JRI, Gaspar HA, de Leeuw CA, Steinberg S, Pavlides JMW, Trzaskowski M, Byrne EM, ... ... Kahn RS, et al. Genome-wide association study identifies 30 loci associated with bipolar disorder. Nature Genetics. PMID 31043756 DOI: 10.1038/S41588-019-0397-8 |
0.31 |
|
| 2019 |
Bossong MG, van Hell HH, Schubart CD, van Saane W, Iseger TA, Jager G, van Osch MJP, Jansma JM, Kahn RS, Boks MP, Ramsey NF. Acute effects of ∆9-tetrahydrocannabinol (THC) on resting state brain function and their modulation by COMT genotype. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 30975584 DOI: 10.1016/J.Euroneuro.2019.03.010 |
0.539 |
|
| 2019 |
Cui LB, Wei Y, Xi YB, Griffa A, De Lange SC, Kahn RS, Yin H, Van den Heuvel MP. Connectome-Based Patterns of First-Episode Medication-Naïve Patients With Schizophrenia. Schizophrenia Bulletin. PMID 30926985 DOI: 10.1093/Schbul/Sbz014 |
0.453 |
|
| 2019 |
Chang X, Collin G, Mandl RCW, Cahn W, Kahn RS. Interhemispheric connectivity and hemispheric specialization in schizophrenia patients and their unaffected siblings. Neuroimage. Clinical. 101656. PMID 30660663 DOI: 10.1016/J.Nicl.2019.101656 |
0.462 |
|
| 2019 |
Yao B, Neggers SFW, Rolfs M, Rösler L, Thompson IA, Hopman HJ, Ghermezi L, Kahn RS, Thakkar KN. Structural thalamo-frontal hypoconnectivity is related to oculomotor corollary discharge dysfunction in schizophrenia. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 30630882 DOI: 10.1523/Jneurosci.1473-18.2019 |
0.387 |
|
| 2019 |
Schirmbeck F, Konijn M, Hoetjes V, Zink M, Haan Ld, Alizadeh BZ, Bartels-Velthuis AA, Bruggeman R, Beveren NJv, Cahn W, Kahn RS, Haren NEv, Haan Ld, Meijer CJ, Simons CJP, et al. Obsessive–compulsive symptoms in psychotic disorders: longitudinal associations of symptom clusters on between- and within-subject levels European Archives of Psychiatry and Clinical Neuroscience. 269: 245-255. PMID 29520640 DOI: 10.1007/S00406-018-0884-4 |
0.304 |
|
| 2019 |
Weiser M, Levi L, Leucht S, Rossum IW, Kahn R. 17.1 PREDICTORS OF RELAPSE IN FIRST EPISODE PSYCHOSIS PATIENTS IN REMISSION Schizophrenia Bulletin. 45: S115-S116. DOI: 10.1093/Schbul/Sbz022.065 |
0.316 |
|
| 2019 |
Merritt K, Perez-Iglesias R, Sendt K, Goozee R, Jauhar S, Pepper F, Barker GJ, Glenthoj B, Arango C, Lewis S, Kahn R, Stone J, Howes O, Dazzan P, McGuire P, et al. O5.6. REMISSION FROM ANTIPSYCHOTIC TREATMENT IN FIRST EPISODE PSYCHOSIS RELATED TO LONGITUDINAL CHANGES IN BRAIN GLUTAMATE LEVELS Schizophrenia Bulletin. 45: S175-S175. DOI: 10.1093/Schbul/Sbz021.214 |
0.309 |
|
| 2019 |
Koevoets M, Prikken M, Hagenaar D, Kahn R, Haren NV. F90. EMOTION PROCESSING AND WHITE MATTER STRUCTURAL CONNECTIVITY IN SCHIZOPHRENIA Schizophrenia Bulletin. 45: S287-S288. DOI: 10.1093/Schbul/Sbz018.502 |
0.353 |
|
| 2019 |
Ori A, Loohuis LO, Guintivano J, Clair DS, McQuillin A, Mill J, Sullivan P, Kahn R, Horvath S, Ophoff R. 30 Schizophrenia Is Characterized By Age- And Sex-Specific Effects On Epigenetic Aging European Neuropsychopharmacology. 29. DOI: 10.1016/J.Euroneuro.2019.07.171 |
0.336 |
|
| 2019 |
Ori A, Horvath S, Kahn R, Ophoff R. F124EPIGENETIC AGING IN BLOOD IS AFFECTED IN SCHIZOPHRENIA European Neuropsychopharmacology. 29: S1177. DOI: 10.1016/J.Euroneuro.2018.08.204 |
0.381 |
|
| 2019 |
Zhang J, Robinson D, Yu J, Gallego J, Fleischhacker WW, Kahn RS, Crespo-Facorro B, Vazquez-Bourgon J, Kane J, Malhotra A, Lencz T. Schizophrenia Polygenic Risk Score Predicts Antipsychotic Treatment Response In Patients With First Episode Psychosis European Neuropsychopharmacology. 29. DOI: 10.1016/J.Euroneuro.2017.08.388 |
0.376 |
|
| 2019 |
Chand GB, Dwyer DB, Erus G, Sotiras A, Varol E, Srinivasan D, Gur RC, Gur RE, Dazzan P, Kahn RS, Schnack HG, Zanetti MV, Busatto GF, Facorro BC, Pantelis C, et al. T195. Neuroanatomical Heterogeneity of Schizophrenia Quantified via Semi-Supervised Machine Learning Reveals Two Distinct Subtypes: Results From the PHENOM Consortium Biological Psychiatry. 85: S205-S206. DOI: 10.1016/J.Biopsych.2019.03.518 |
0.322 |
|
| 2019 |
Zwarte Sd, Brouwer R, Ching C, Andreassen O, Erp Tv, Turner J, Thompson P, Kahn R, Haren Nv. 21. ENIGMA-Relatives: The Association Between Familial Risk for Schizophrenia or Bipolar Disorder and Brain Abnormalities Biological Psychiatry. 85. DOI: 10.1016/J.Biopsych.2019.03.035 |
0.395 |
|
| 2018 |
de Zwarte SMC, Brouwer RM, Tsouli A, Cahn W, Hillegers MHJ, Hulshoff Pol HE, Kahn RS, van Haren NEM. Running in the Family? Structural Brain Abnormalities and IQ in Offspring, Siblings, Parents, and Co-twins of Patients with Schizophrenia. Schizophrenia Bulletin. PMID 30597053 DOI: 10.1093/Schbul/Sby182 |
0.448 |
|
| 2018 |
Swets M, van Dijk FA, Schirmbeck F, Peen J, de Haan L, Alizadeh BZ, van Amelsvoort T, Bartels-Velthuis AA, van Beveren NJ, Bruggeman R, Cahn W, Delespaul P, Luykx JJ, Myin-Germeys I, Kahn RS, et al. Patterns of obsessive-compulsive symptoms and social functioning in schizophrenia; a replication study. Psychiatry Research. 271: 421-427. PMID 30537664 DOI: 10.1016/J.Psychres.2018.11.071 |
0.307 |
|
| 2018 |
Prikken M, van der Weiden A, Baalbergen H, Hillegers MH, Kahn RS, Aarts H, van Haren NE. Spontaneous low-frequency fluctuations in the neural system for emotional perception in major psychiatric disorders: amplitude similarities and differences across frequency bands Journal of Psychiatry & Neuroscience : Jpn. 44: 1-8. PMID 30525317 DOI: 10.1503/Jpn.180049 |
0.373 |
|
| 2018 |
Zhang JP, Robinson D, Yu J, Gallego J, Fleischhacker WW, Kahn RS, Crespo-Facorro B, Vazquez-Bourgon J, Kane JM, Malhotra AK, Lencz T. Schizophrenia Polygenic Risk Score as a Predictor of Antipsychotic Efficacy in First-Episode Psychosis. The American Journal of Psychiatry. appiajp201817121363. PMID 30392411 DOI: 10.1176/Appi.Ajp.2018.17121363 |
0.412 |
|
| 2018 |
van Bergen AH, Verkooijen S, Vreeker A, Abramovic L, Hillegers MH, Spijker AT, Hoencamp E, Regeer EJ, Knapen SE, Riemersma-van der Lek RF, Schoevers R, Stevens AW, Schulte PFJ, Vonk R, Hoekstra R, ... ... Kahn RS, et al. The characteristics of psychotic features in bipolar disorder. Psychological Medicine. 1-13. PMID 30303059 DOI: 10.1017/S0033291718002854 |
0.303 |
|
| 2018 |
de Nijs J, Schnack HG, Koevoets MGJC, Kubota M, Kahn RS, van Haren NEM, Cahn W. Reward-related brain structures are smaller in patients with schizophrenia and comorbid metabolic syndrome. Acta Psychiatrica Scandinavica. PMID 30264457 DOI: 10.1111/Acps.12955 |
0.387 |
|
| 2018 |
van Leeuwen JMC, Vink M, Joëls M, Kahn RS, Hermans EJ, Vinkers CH. Increased responses of the reward circuitry to positive task feedback following acute stress in healthy controls but not in siblings of schizophrenia patients. Neuroimage. PMID 30243958 DOI: 10.1016/J.Neuroimage.2018.09.051 |
0.656 |
|
| 2018 |
Boks MP, Houtepen LC, Xu Z, He Y, Ursini G, Maihofer AX, Rajarajan P, Yu Q, Xu H, Wu Y, Wang S, Shi JP, Hulshoff Pol HE, Strengman E, Rutten BPF, ... ... Kahn RS, et al. Genetic vulnerability to DUSP22 promoter hypermethylation is involved in the relation between in utero famine exposure and schizophrenia. Npj Schizophrenia. 4: 16. PMID 30131491 DOI: 10.1038/S41537-018-0058-4 |
0.358 |
|
| 2018 |
Kahn RS, Winter van Rossum I, Leucht S, McGuire P, Lewis SW, Leboyer M, Arango C, Dazzan P, Drake R, Heres S, Díaz-Caneja CM, Rujescu D, Weiser M, Galderisi S, Glenthøj B, et al. Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study. The Lancet. Psychiatry. PMID 30115598 DOI: 10.1016/S2215-0366(18)30252-9 |
0.416 |
|
| 2018 |
Fiksinski AM, Breetvelt EJ, Lee YJ, Boot E, Butcher N, Palmer L, Chow EWC, Kahn RS, Vorstman JAS, Bassett AS. Neurocognition and adaptive functioning in a genetic high risk model of schizophrenia. Psychological Medicine. 1-8. PMID 30064532 DOI: 10.1017/S0033291718001824 |
0.381 |
|
| 2018 |
Kahn RS. On the Continued Benefit of Antipsychotics After the First Episode of Schizophrenia. The American Journal of Psychiatry. 175: 712-713. PMID 30064241 DOI: 10.1176/Appi.Ajp.2018.18060639 |
0.419 |
|
| 2018 |
Schür RR, van Leeuwen JMC, Houtepen LC, Joëls M, Kahn RS, Boks MP, Vinkers CH. Glucocorticoid receptor exon 1 methylation and the cortisol stress response in health and disease. Psychoneuroendocrinology. 97: 182-189. PMID 30036796 DOI: 10.1016/J.Psyneuen.2018.07.018 |
0.569 |
|
| 2018 |
Oviedo-Salcedo T, de Witte L, Kümpfel T, Kahn RS, Falkai P, Eichhorn P, Luykx J, Hasan A. Absence of cerebrospinal fluid antineuronal antibodies in schizophrenia spectrum disorders - CORRIGENDUM. The British Journal of Psychiatry : the Journal of Mental Science. 1. PMID 29986772 DOI: 10.1192/Bjp.2018.77 |
0.363 |
|
| 2018 |
van Erp TGM, Walton E, Hibar DP, Schmaal L, Jiang W, Glahn DC, Pearlson GD, Yao N, Fukunaga M, Hashimoto R, Okada N, Yamamori H, Bustillo JR, Clark VP, Agartz I, ... ... Kahn RS, et al. Cortical Brain Abnormalities in 4474 Individuals With Schizophrenia and 5098 Control Subjects via the Enhancing Neuro Imaging Genetics Through Meta Analysis (ENIGMA) Consortium. Biological Psychiatry. PMID 29960671 DOI: 10.1016/j.biopsych.2018.04.023 |
0.33 |
|
| 2018 |
Bilderbeck AC, Penninx BWJH, Arango C, van der Wee N, Kahn R, Winter-van Rossum I, Hayen A, Kas MJ, Post A, Dawson GR. Overview of the clinical implementation of a study exploring social withdrawal in patients with schizophrenia and Alzheimer's disease. Neuroscience and Biobehavioral Reviews. PMID 29940238 DOI: 10.1016/J.Neubiorev.2018.06.019 |
0.577 |
|
| 2018 |
Egerton A, Broberg BV, Van Haren N, Merritt K, Barker GJ, Lythgoe DJ, Perez-Iglesias R, Baandrup L, Düring SW, Sendt KV, Stone JM, Rostrup E, Sommer IE, Glenthøj B, Kahn RS, et al. Response to initial antipsychotic treatment in first episode psychosis is related to anterior cingulate glutamate levels: a multicentre H-MRS study (OPTiMiSE). Molecular Psychiatry. PMID 29880882 DOI: 10.1038/S41380-018-0082-9 |
0.383 |
|
| 2018 |
de Nijs J, Meijer JH, de Haan L, Meijer CJ, Bruggeman R, van Haren NEM, Kahn RS, Cahn W. Associations between olfactory identification and (social) cognitive functioning: A cross-sectional study in schizophrenia patients and healthy controls. Psychiatry Research. 266: 147-151. PMID 29864614 DOI: 10.1016/J.Psychres.2018.05.009 |
0.328 |
|
| 2018 |
Abramovic L, Boks MPM, Vreeker A, Verkooijen S, van Bergen AH, Ophoff RA, Kahn RS, van Haren NEM. White matter disruptions in patients with bipolar disorder. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 29779901 DOI: 10.1016/J.Euroneuro.2018.01.001 |
0.345 |
|
| 2018 |
Vorstman JAS, Olde Loohuis LM, Kahn RS, Ophoff RA. Double Hits in Schizophrenia. Human Molecular Genetics. PMID 29767709 DOI: 10.1093/Hmg/Ddy175 |
0.386 |
|
| 2018 |
Olde Loohuis LM, Mangul S, Ori APS, Jospin G, Koslicki D, Yang HT, Wu T, Boks MP, Lomen-Hoerth C, Wiedau-Pazos M, Cantor RM, de Vos WM, Kahn RS, Eskin E, Ophoff RA. Transcriptome analysis in whole blood reveals increased microbial diversity in schizophrenia. Translational Psychiatry. 8: 96. PMID 29743478 DOI: 10.1038/S41398-018-0107-9 |
0.419 |
|
| 2018 |
van Leeuwen JMC, Vink M, Fernández G, Hermans EJ, Joëls M, Kahn RS, Vinkers CH. At-risk individuals display altered brain activity following stress. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 29483659 DOI: 10.1038/S41386-018-0026-8 |
0.683 |
|
| 2018 |
Tomasik J, Smits SL, Leweke FM, Eljasz P, Pas S, Kahn RS, Osterhaus ADME, Bahn S, de Witte LD. Virus discovery analyses on post-mortem brain tissue and cerebrospinal fluid of schizophrenia patients. Schizophrenia Research. PMID 29478863 DOI: 10.1016/J.Schres.2018.02.012 |
0.385 |
|
| 2018 |
Linscott RJ, Morton SE, Alizadeh BZ, Bartels-Velthuis AA, Beveren NJV, Bruggeman R, Cahn W, Haan LD, Delespaul P, Meijer CJ, Myin-Germeys I, Kahn RS, Schirmbeck F, Simons CJP, Haren NEV, et al. The Latent Taxonicity of Schizotypy in Biological Siblings of Probands With Schizophrenia. Schizophrenia Bulletin. 44: 922-932. PMID 29036385 DOI: 10.1093/Schbul/Sbx143 |
0.387 |
|
| 2018 |
Salcedo TO, Gagsteiger A, de Witte L, Kümpfel T, Kahn R, Falkai P, Eichhorn P, Luykx J, Hasan A. F107. CSF ABNORMALITIES IN SCHIZOPHRENIA AND DEPRESSION: PRELIMINARY RESULTS FROM A LARGE SCALE COHORT Schizophrenia Bulletin. 44: S261-S261. DOI: 10.1093/Schbul/Sby017.638 |
0.333 |
|
| 2018 |
van Haren N, Nikita S, Koevoets M, Baalbergen H, Vink M, Mesman E, Kahn R, Hillegers M. F17. DIFFERENCES IN INTRACRANIAL VOLUME, IQ AND PSYCHOPATHOLOGY IN YOUNG OFFSPRING OF PATIENTS AFFECTED WITH SCHIZOPHRENIA OR BIPOLAR DISORDER Schizophrenia Bulletin. 44: S225-S225. DOI: 10.1093/Schbul/Sby017.548 |
0.693 |
|
| 2018 |
Boks M, Houtepen L, Xu Z, He Y, Ursini G, Maihofer A, Rajarajan P, Hulshoff Pol H, Rutten B, Jaffe AE, Kleinmann JE, Baker D, Hol E, Akbarian S, Nievergelt C, ... ... Kahn R, et al. O4.1. GENETIC VULNERABILITY TO DUSP22 PROMOTOR HYPERMETHYLATION IS INVOLVED IN THE RELATION BETWEEN IN UTERO FAMINE EXPOSURE AND SCHIZOPHRENIA Schizophrenia Bulletin. 44: S82-S82. DOI: 10.1093/Schbul/Sby015.207 |
0.372 |
|
| 2018 |
Van Haren N, Prikken M, van der Weiden A, Baalbergen H, Hillegers M, Aarts H, Kahn R. O2.5. MULTISENSORY INTEGRATION UNDERLYING BODY OWNERSHIP IN SCHIZOPHRENIA AND INDIVIDUALS AT FAMILIAL RISK TO DEVELOP PSYCHOSIS: A STUDY USING THE RUBBER HAND ILLUSION PARADIGM Schizophrenia Bulletin. 44: S77-S77. DOI: 10.1093/Schbul/Sby015.195 |
0.409 |
|
| 2018 |
Dazzan P, Reinders AS, Shatzi V, Carletti F, Arango C, Fleischhacker W, Galderisi S, Mucci A, Glenthoj B, Egerton A, Barker G, Leucht S, Meyer-Lindenberg A, Kahn RS, Rujescu D, et al. 31.3 CLINICAL UTILITY OF MRI SCANNING IN FIRST EPISODE PSYCHOSIS Schizophrenia Bulletin. 44: S50-S51. DOI: 10.1093/Schbul/Sby014.129 |
0.348 |
|
| 2018 |
Kahn R. 31.1 Optimising The Treatment And Management Of First-Episode Schizophrenia: The Optimise Clinical Trial Schizophrenia Bulletin. 44. DOI: 10.1093/Schbul/Sby014.127 |
0.337 |
|
| 2018 |
Schnack H, Binnewies J, Setiaman N, Berdowski W, van Haren N, Kahn R, Hillegers M. F172. INDIVIDUAL PREDICTION OF RISK IN ADOLESCENT OFFSPRING OF PARENTS WITH SCHIZOPHRENIA OR BIPOLAR DISORDER: A MACHINE LEARNING NEUROIMAGING STUDY WITH A CROSS-STAGE VALIDATION Schizophrenia Bulletin. 44: S287-S288. DOI: 10.1016/J.Jaac.2018.07.767 |
0.327 |
|
| 2018 |
van Leeuwen J, Vink M, Fernández G, Hermans E, Joëls M, Kahn R, Vinkers C. F228. Functional Activation Abnormalities Following Stress in At-Risk Individuals Biological Psychiatry. 83: S327. DOI: 10.1016/J.Biopsych.2018.02.842 |
0.617 |
|
| 2018 |
de Zwarte S, Brouwer R, Tsouli A, Cahn W, Hillegers M, Pol HH, Kahn R, van Haren N. F221. Brain Abnormalities and Cognitive Deficits in First-Degree Relatives of Patients With Schizophrenia Biological Psychiatry. 83: S325. DOI: 10.1016/J.Biopsych.2018.02.835 |
0.392 |
|
| 2018 |
Fiksinski A, Breetvelt E, Vorstman J, Lee E, Boot E, Butcher N, Palmer L, Chow E, Kahn R, Bassett A. F207. Neurocognition and Adaptive Functioning in the 22q11.2 Deletion Syndrome Model of Schizophrenia Biological Psychiatry. 83: S319. DOI: 10.1016/J.Biopsych.2018.02.821 |
0.341 |
|
| 2018 |
Föcking M, Pollak T, Dicker P, Cagney G, Winter I, Kahn R, McGuire P, Cotter D. O1.7. PROTEOMIC ANALYSIS OF BLOOD BASED SAMPLES FROM THE OPTiMiSE (OPTIMIZATION OF TREATMENT AND MANAGEMENT OF SCHIZOPHRENIA IN EUROPE) STUDY POINT TOWARDS COMPLEMENT PATHWAY PROTEIN CHANGES Schizophrenia Bulletin. 44: S74-S75. DOI: 10.1016/J.Biopsych.2018.02.775 |
0.313 |
|
| 2018 |
Breetvelt E, Smit K, Loohuis LO, Ophoff R, Kahn R, Vorstman J. T225. Burden of Rare Coding Variants in the 22q11.2 Deletion Syndrome Region is Associated With Educational Attainment and Schizophrenia Risk Biological Psychiatry. 83. DOI: 10.1016/J.Biopsych.2018.02.562 |
0.31 |
|
| 2017 |
Nuninga JO, Bohlken MM, Koops S, Fiksinski AM, Mandl RCW, Breetvelt EJ, Duijff SN, Kahn RS, Sommer IEC, Vorstman JAS. White matter abnormalities in 22q11.2 deletion syndrome patients showing cognitive decline. Psychological Medicine. 1-9. PMID 29143717 DOI: 10.1017/S0033291717003142 |
0.374 |
|
| 2017 |
Blakey R, Ranlund S, Zartaloudi E, Cahn W, Calafato S, Colizzi M, Crespo-Facorro B, Daniel C, Díez-Revuelta Á, Di Forti M, Iyegbe C, Jablensky A, Jones R, Hall MH, ... Kahn R, et al. Associations between psychosis endophenotypes across brain functional, structural, and cognitive domains. Psychological Medicine. 1-20. PMID 29094675 DOI: 10.1017/S0033291717002860 |
0.312 |
|
| 2017 |
Kahn RS. Why the concept of schizophrenia is still alive and kicking. Psychological Medicine. 1-2. PMID 29072152 DOI: 10.1017/S0033291717002069 |
0.395 |
|
| 2017 |
Kelly S, Jahanshad N, Zalesky A, Kochunov P, Agartz I, Alloza C, Andreassen OA, Arango C, Banaj N, Bouix S, Bousman CA, Brouwer RM, Bruggemann J, Bustillo J, Cahn W, ... ... Kahn RS, et al. Widespread white matter microstructural differences in schizophrenia across 4322 individuals: results from the ENIGMA Schizophrenia DTI Working Group. Molecular Psychiatry. PMID 29038599 DOI: 10.1038/Mp.2017.170 |
0.437 |
|
| 2017 |
Blokland GAM, Del Re EC, Mesholam-Gately RI, Jovicich J, Trampush JW, Keshavan MS, DeLisi LE, Walters JTR, Turner JA, Malhotra AK, Lencz T, Shenton ME, Voineskos AN, Rujescu D, Giegling I, ... Kahn RS, et al. The Genetics of Endophenotypes of Neurofunction to Understand Schizophrenia (GENUS) consortium: A collaborative cognitive and neuroimaging genetics project. Schizophrenia Research. PMID 28982554 DOI: 10.1016/J.Schres.2017.09.024 |
0.407 |
|
| 2017 |
Marsman A, Mandl RCW, Klomp DWJ, Cahn W, Kahn RS, Luijten PR, Hulshoff Pol HE. Intelligence and Brain Efficiency: Investigating the Association between Working Memory Performance, Glutamate, and GABA. Frontiers in Psychiatry. 8: 154. PMID 28966597 DOI: 10.3389/Fpsyt.2017.00154 |
0.301 |
|
| 2017 |
van Mierlo HC, Wichers CGK, He Y, Sneeboer MAM, Radstake TRDJ, Kahn RS, Broen JCA, de Witte LD. Telomere quantification in frontal and temporal brain tissue of patients with schizophrenia. Journal of Psychiatric Research. 95: 231-234. PMID 28910708 DOI: 10.1016/J.Jpsychires.2017.09.006 |
0.431 |
|
| 2017 |
Collin G, Scholtens LH, Kahn RS, Hillegers MHJ, van den Heuvel MP. Affected Anatomical Rich Club and Structural-Functional Coupling in Young Offspring of Schizophrenia and Bipolar Disorder Patients. Biological Psychiatry. PMID 28734460 DOI: 10.1016/J.Biopsych.2017.06.013 |
0.41 |
|
| 2017 |
Vreeker A, Abramovic L, Boks MPM, Verkooijen S, van Bergen AH, Ophoff RA, Kahn RS, van Haren NEM. The relationship between brain volumes and intelligence in bipolar disorder. Journal of Affective Disorders. 223: 59-64. PMID 28728036 DOI: 10.1016/J.Jad.2017.07.009 |
0.355 |
|
| 2017 |
Witt SH, Streit F, Jungkunz M, Frank J, Awasthi S, Reinbold CS, Treutlein J, Degenhardt F, Forstner AJ, Heilmann-Heimbach S, Dietl L, Schwarze CE, Schendel D, Strohmaier J, Abdellaoui A, ... ... Kahn RS, et al. Genome-wide association study of borderline personality disorder reveals genetic overlap with bipolar disorder, major depression and schizophrenia. Translational Psychiatry. 7: e1155. PMID 28632202 DOI: 10.1038/Tp.2017.115 |
0.336 |
|
| 2017 |
Wei Y, Collin G, Mandl RCW, Cahn W, Keunen K, Schmidt R, Kahn RS, van den Heuvel MP. Cortical magnetization transfer abnormalities and connectome dysconnectivity in schizophrenia. Schizophrenia Research. PMID 28601503 DOI: 10.1016/J.Schres.2017.05.029 |
0.437 |
|
| 2017 |
Brouwer RM, Panizzon MS, Glahn DC, Hibar DP, Hua X, Jahanshad N, Abramovic L, de Zubicaray GI, Franz CE, Hansell NK, Hickie IB, Koenis MMG, Martin NG, Mather KA, McMahon KL, ... ... Kahn RS, et al. Genetic influences on individual differences in longitudinal changes in global and subcortical brain volumes: Results of the ENIGMA plasticity working group. Human Brain Mapping. PMID 28580697 DOI: 10.1002/Hbm.23672 |
0.316 |
|
| 2017 |
Walton E, Hibar DP, van Erp TGM, Potkin SG, Roiz-Santiañez R, Crespo-Facorro B, Suarez-Pinilla P, van Haren NEM, de Zwarte SMC, Kahn RS, Cahn W, Doan NT, Jørgensen KN, Gurholt TP, Agartz I, et al. Prefrontal cortical thinning links to negative symptoms in schizophrenia via the ENIGMA consortium. Psychological Medicine. 1-13. PMID 28545597 DOI: 10.1017/S0033291717001283 |
0.418 |
|
| 2017 |
Hibar DP, Westlye LT, Doan NT, Jahanshad N, Cheung JW, Ching CRK, Versace A, Bilderbeck AC, Uhlmann A, Mwangi B, Krämer B, Overs B, Hartberg CB, Abé C, Dima D, ... ... Kahn RS, et al. Cortical abnormalities in bipolar disorder: an MRI analysis of 6503 individuals from the ENIGMA Bipolar Disorder Working Group. Molecular Psychiatry. PMID 28461699 DOI: 10.1038/Mp.2017.73 |
0.371 |
|
| 2017 |
de With SAJ, Pulit SL, Staal WG, Kahn RS, Ophoff RA. More than 25 years of genetic studies of clozapine-induced agranulocytosis. The Pharmacogenomics Journal. PMID 28418011 DOI: 10.1038/Tpj.2017.6 |
0.632 |
|
| 2017 |
Walton E, Hibar DP, van Erp TG, Potkin SG, Roiz-Santiañez R, Crespo-Facorro B, Suarez-Pinilla P, Van Haren NE, de Zwarte SM, Kahn RS, Cahn W, Doan NT, Jørgensen KN, Gurholt TP, Agartz I, et al. Positive symptoms associate with cortical thinning in the superior temporal gyrus via the ENIGMA Schizophrenia consortium. Acta Psychiatrica Scandinavica. PMID 28369804 DOI: 10.1111/Acps.12718 |
0.383 |
|
| 2017 |
van Kesteren CF, Gremmels H, de Witte LD, Hol EM, Van Gool AR, Falkai PG, Kahn RS, Sommer IE. Immune involvement in the pathogenesis of schizophrenia: a meta-analysis on postmortem brain studies. Translational Psychiatry. 7: e1075. PMID 28350400 DOI: 10.1038/Tp.2017.4 |
0.44 |
|
| 2017 |
Keefe RS, Kahn RS. Cognitive Decline and Disrupted Cognitive Trajectory in Schizophrenia. Jama Psychiatry. PMID 28329400 DOI: 10.1001/Jamapsychiatry.2017.0312 |
0.326 |
|
| 2017 |
McLaughlin RL, Schijven D, van Rheenen W, van Eijk KR, O'Brien M, Kahn RS, Ophoff RA, Goris A, Bradley DG, Al-Chalabi A, van den Berg LH, Luykx JJ, Hardiman O, Veldink JH, et al. Genetic correlation between amyotrophic lateral sclerosis and schizophrenia. Nature Communications. 8: 14774. PMID 28322246 DOI: 10.1038/Ncomms14774 |
0.404 |
|
| 2017 |
Chang X, Collin G, Xi Y, Cui L, Scholtens LH, Sommer IE, Wang H, Yin H, Kahn RS, van den Heuvel MP. Resting-state functional connectivity in medication-naïve schizophrenia patients with and without auditory verbal hallucinations: A preliminary report. Schizophrenia Research. PMID 28130005 DOI: 10.1016/J.Schres.2017.01.024 |
0.432 |
|
| 2017 |
Fiksinski AM, Breetvelt EJ, Duijff SN, Bassett AS, Kahn RS, Vorstman JA. Autism Spectrum and psychosis risk in the 22q11.2 deletion syndrome. Findings from a prospective longitudinal study. Schizophrenia Research. PMID 28119035 DOI: 10.1016/J.Schres.2017.01.032 |
0.352 |
|
| 2017 |
Hibar DP, Adams HH, Jahanshad N, Chauhan G, Stein JL, Hofer E, Renteria ME, Bis JC, Arias-Vasquez A, Ikram MK, Desrivières S, Vernooij MW, Abramovic L, Alhusaini S, Amin N, ... ... Kahn RS, et al. Novel genetic loci associated with hippocampal volume. Nature Communications. 8: 13624. PMID 28098162 DOI: 10.1038/Ncomms13624 |
0.751 |
|
| 2017 |
Egerton A, Merritt K, McQueen G, Howes O, Demjaha A, Brugger S, Barker G, Stone J, Dazzan P, Broberg B, van Haren N, Glenthoj B, Kahn R, McGuire P. SA83. Brain Glutamate Levels and Antipsychotic Response in Schizophrenia Schizophrenia Bulletin. 43: S142-S143. DOI: 10.1093/Schbul/Sbx023.081 |
0.412 |
|
| 2017 |
Collin G, Hillegers M, Scholtens L, Kahn R, van den Heuvel M. 166. Affected Anatomical Rich Club Core and Structural–Functional Integration in Young Offspring of Schizophrenia and Bipolar Disorder Patients Schizophrenia Bulletin. 43: S84-S84. DOI: 10.1093/Schbul/Sbx021.224 |
0.413 |
|
| 2017 |
Van Leeuwen J, Vink M, Fernández G, Hermans E, Joëls M, Kahn R, Vinkers C. The dynamic brain response to stress is impaired in siblings of schizophrenia patients European Neuropsychopharmacology. 27: S548. DOI: 10.1016/S0924-977X(17)31047-7 |
0.7 |
|
| 2017 |
Van Leeuwen J, Vink M, Joëls M, Kahn R, Vinkers C. Psychosocial stress and emotion processing in siblings of schizophrenia patients European Neuropsychopharmacology. 27: S76. DOI: 10.1016/S0924-977X(16)31211-1 |
0.679 |
|
| 2017 |
Lencz T, Zhang J, Kahn RS, Ophoff R, Wolfgang Fleischhacker W, Emsley R, Robinson D, Correll C, Malhotra A. Pharmacogenetics of Antipsychotic-Induced Weight Gain in Multiple Medication-Naive Cohorts European Neuropsychopharmacology. 27: S499. DOI: 10.1016/J.Euroneuro.2016.09.599 |
0.306 |
|
| 2017 |
Zwarte Sd, Brouwer R, Hillegers M, Cahn W, Pol HH, Kahn R, Alpert K, Wang L, Bramon E, Kane F, Murray R, Hajek T, Alda M, Roberts G, Mitchell P, et al. 278. ENIGMA-Relatives – Brain Volumes in First-Degree Relatives of Schizophrenia and Bipolar Patients Biological Psychiatry. 81. DOI: 10.1016/J.Biopsych.2017.02.292 |
0.43 |
|
| 2016 |
Prikken M, van der Weiden A, Renes RA, Koevoets MG, Heering HD, Kahn RS, Aarts H, van Haren NE. Abnormal agency experiences in schizophrenia patients: Examining the role of psychotic symptoms and familial risk. Psychiatry Research. 250: 270-276. PMID 28189096 DOI: 10.1016/J.Psychres.2016.10.077 |
0.385 |
|
| 2016 |
Zorn JV, Schür RR, Boks MP, Kahn RS, Joëls M, Vinkers CH. Cortisol stress reactivity across psychiatric disorders: A systematic review and meta-analysis. Psychoneuroendocrinology. 77: 25-36. PMID 28012291 DOI: 10.1016/J.Psyneuen.2016.11.036 |
0.579 |
|
| 2016 |
Tempelaar WM, Termorshuizen F, MacCabe JH, Boks MP, Kahn RS. Educational achievement in psychiatric patients and their siblings: a register-based study in 30 000 individuals in The Netherlands. Psychological Medicine. 1-9. PMID 27873559 DOI: 10.1017/S0033291716002877 |
0.338 |
|
| 2016 |
de Leeuw AS, van Megen HJ, Kahn RS, Westenberg HG. d-cycloserine addition to exposure sessions in the treatment of patients with obsessive-compulsive disorder. European Psychiatry : the Journal of the Association of European Psychiatrists. 40: 38-44. PMID 27837671 DOI: 10.1016/J.Eurpsy.2016.06.011 |
0.546 |
|
| 2016 |
Romme IA, de Reus MA, Ophoff RA, Kahn RS, van den Heuvel MP. Connectome Disconnectivity and Cortical Gene Expression in Patients With Schizophrenia. Biological Psychiatry. PMID 27720199 DOI: 10.1016/J.Biopsych.2016.07.012 |
0.429 |
|
| 2016 |
Adams HH, Hibar DP, Chouraki V, Stein JL, Nyquist PA, Rentería ME, Trompet S, Arias-Vasquez A, Seshadri S, Desrivières S, Beecham AH, Jahanshad N, Wittfeld K, Van der Lee SJ, Abramovic L, ... ... Kahn RS, et al. Novel genetic loci underlying human intracranial volume identified through genome-wide association. Nature Neuroscience. PMID 27694991 DOI: 10.1038/Nn.4398 |
0.731 |
|
| 2016 |
de Wit S, Wierenga LM, Oranje B, Ziermans TB, Schothorst PF, van Engeland H, Kahn RS, Durston S. Brain development in adolescents at ultra-high risk for psychosis: Longitudinal changes related to resilience. Neuroimage. Clinical. 12: 542-549. PMID 27672558 DOI: 10.1016/J.Nicl.2016.08.013 |
0.315 |
|
| 2016 |
Abramovic L, Boks MP, Vreeker A, Bouter DC, Kruiper C, Verkooijen S, van Bergen AH, Ophoff RA, Kahn RS, van Haren NE. The association of antipsychotic medication and lithium with brain measures in patients with bipolar disorder. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 27665062 DOI: 10.1016/J.Euroneuro.2016.09.371 |
0.382 |
|
| 2016 |
van der Doef TF, de Witte LD, Sutterland AL, Jobse E, Yaqub M, Boellaard R, de Haan L, Eriksson J, Lammertsma AA, Kahn RS, van Berckel BN. In vivo (R)-[(11)C]PK11195 PET imaging of 18kDa translocator protein in recent onset psychosis. Npj Schizophrenia. 2: 16031. PMID 27602389 DOI: 10.1038/Npjschz.2016.31 |
0.371 |
|
| 2016 |
Schür RR, Boks MP, Geuze E, Prinsen HC, Verhoeven-Duif NM, Joëls M, Kahn RS, Vermetten E, Vinkers CH. Development of psychopathology in deployed armed forces in relation to plasma GABA levels. Psychoneuroendocrinology. 73: 263-270. PMID 27566489 DOI: 10.1016/J.Psyneuen.2016.08.014 |
0.545 |
|
| 2016 |
Collin G, Kahn RS. Schizophrenia in the Era of Brain Complexity. The Journal of Nervous and Mental Disease. 204: 561-3. PMID 27479610 DOI: 10.1097/Nmd.0000000000000545 |
0.413 |
|
| 2016 |
de Leeuw M, Bohlken MM, Mandl RC, Hillegers MH, Kahn RS, Vink M. Changes in White Matter Organization in Adolescent Offspring of Schizophrenia Patients. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 27440007 DOI: 10.1038/Npp.2016.130 |
0.711 |
|
| 2016 |
Schnack H, Haren Nv, Hillegers M, Kahn R. Individual prediction of risk in adolescent offspring of parents with bipolar disorder and schizophrenia using machine learning in MRI brain scans Bipolar Disorders. 18: 64-64. PMID 27373790 DOI: 10.1111/Bdi.12406 |
0.323 |
|
| 2016 |
Thakkar KN, Rösler L, Wijnen JP, Boer VO, Klomp DW, Cahn W, Kahn RS, Neggers SF. 7T Proton Magnetic Resonance Spectroscopy of Gamma-Aminobutyric Acid, Glutamate, and Glutamine Reveals Altered Concentrations in Patients With Schizophrenia and Healthy Siblings. Biological Psychiatry. PMID 27316853 DOI: 10.1016/J.Biopsych.2016.04.007 |
0.367 |
|
| 2016 |
Buoli M, Kahn RS, Serati M, Altamura AC, Cahn W. Haloperidol versus second-generation antipsychotics in the long-term treatment of schizophrenia. Human Psychopharmacology. PMID 27297936 DOI: 10.1002/Hup.2542 |
0.401 |
|
| 2016 |
Bootsman F, Brouwer RM, Schnack HG, Kemner SM, Hillegers MH, Sarkisyan G, van der Schot AC, Vonk R, Hulshoff Pol HE, Nolen WA, Kahn RS, van Haren NE. A study of genetic and environmental contributions to structural brain changes over time in twins concordant and discordant for bipolar disorder. Journal of Psychiatric Research. 79: 116-124. PMID 27218817 DOI: 10.1016/J.Jpsychires.2016.04.011 |
0.363 |
|
| 2016 |
Zhang JP, Lencz T, Zhang RX, Nitta M, Maayan L, John M, Robinson DG, Fleischhacker WW, Kahn RS, Ophoff RA, Kane JM, Malhotra AK, Correll CU. Pharmacogenetic Associations of Antipsychotic Drug-Related Weight Gain: A Systematic Review and Meta-analysis. Schizophrenia Bulletin. PMID 27217270 DOI: 10.1093/Schbul/Sbw058 |
0.302 |
|
| 2016 |
Janssens M, Boyette LL, Heering HD, Bartels-Velthuis AA, Lataster T, Kahn RS, Haan Ld, Os Jv, Wiersma D, Bruggeman R, Cahn W, Meijer C, Myin-Germeys I. Developmental course of subclinical positive and negative psychotic symptoms and their associations with genetic risk status and impairment Schizophrenia Research. 174: 177-182. PMID 27157801 DOI: 10.1016/J.Schres.2016.03.028 |
0.303 |
|
| 2016 |
Schür RR, Draisma LW, Wijnen JP, Boks MP, Koevoets MG, Joëls M, Klomp DW, Kahn RS, Vinkers CH. Brain GABA levels across psychiatric disorders: A systematic literature review and meta-analysis of (1) H-MRS studies. Human Brain Mapping. PMID 27145016 DOI: 10.1002/Hbm.23244 |
0.609 |
|
| 2016 |
van Haren NE, Kahn RS. Progressive brain tissue loss in schizophrenia. Schizophrenia Research. PMID 27094719 DOI: 10.1016/J.Schres.2016.03.023 |
0.398 |
|
| 2016 |
Thakkar KN, van den Heiligenberg FM, Kahn RS, Neggers SF. Speed of saccade execution and inhibition associated with fractional anisotropy in distinct fronto-frontal and fronto-striatal white matter pathways. Human Brain Mapping. PMID 27091670 DOI: 10.1002/Hbm.23209 |
0.351 |
|
| 2016 |
Schnack HG, Kahn RS. Detecting Neuroimaging Biomarkers for Psychiatric Disorders: Sample Size Matters. Frontiers in Psychiatry. 7: 50. PMID 27064972 DOI: 10.3389/Fpsyt.2016.00050 |
0.338 |
|
| 2016 |
Bohlken MM, Brouwer RM, Mandl RC, Kahn RS, Hulshoff Pol HE. Genetic Variation in Schizophrenia Liability is Shared With Intellectual Ability and Brain Structure. Schizophrenia Bulletin. PMID 27056715 DOI: 10.1093/Schbul/Sbw034 |
0.405 |
|
| 2016 |
Gifford G, Crossley N, Fusar-Poli P, Schnack HG, Kahn RS, Koutsouleris N, Cannon TD, McGuire P. Using neuroimaging to help predict the onset of psychosis. Neuroimage. PMID 27039698 DOI: 10.1016/J.Neuroimage.2016.03.075 |
0.465 |
|
| 2016 |
Houtepen LC, Vinkers CH, Carrillo-Roa T, Hiemstra M, van Lier PA, Meeus W, Branje S, Heim CM, Nemeroff CB, Mill J, Schalkwyk LC, Creyghton MP, Kahn RS, Joëls M, Binder EB, et al. Genome-wide DNA methylation levels and altered cortisol stress reactivity following childhood trauma in humans. Nature Communications. 7: 10967. PMID 26997371 DOI: 10.1038/Ncomms10967 |
0.549 |
|
| 2016 |
Millan MJ, Andrieux A, Bartzokis G, Cadenhead K, Dazzan P, Fusar-Poli P, Gallinat J, Giedd J, Grayson DR, Heinrichs M, Kahn R, Krebs MO, Leboyer M, Lewis D, Marin O, et al. Altering the course of schizophrenia: progress and perspectives. Nature Reviews. Drug Discovery. PMID 26939910 DOI: 10.1038/Nrd.2016.28 |
0.43 |
|
| 2016 |
Landolt K, Rössler W, Ajdacic-Gross V, Derks EM, Libiger J, Kahn RS, Fleischhacker WW. Predictors of discontinuation of antipsychotic medication and subsequent outcomes in the European First Episode Schizophrenia Trial (EUFEST). Schizophrenia Research. PMID 26922655 DOI: 10.1016/J.Schres.2016.01.046 |
0.349 |
|
| 2016 |
Schnack HG, van Haren NE, Nieuwenhuis M, Hulshoff Pol HE, Cahn W, Kahn RS. Accelerated Brain Aging in Schizophrenia: A Longitudinal Pattern Recognition Study. The American Journal of Psychiatry. appiajp201515070922. PMID 26917166 DOI: 10.1176/Appi.Ajp.2015.15070922 |
0.396 |
|
| 2016 |
Kleerekooper I, van Rooij SJ, van den Wildenberg WP, de Leeuw M, Kahn RS, Vink M. The effect of aging on fronto-striatal reactive and proactive inhibitory control. Neuroimage. PMID 26899783 DOI: 10.1016/J.Neuroimage.2016.02.031 |
0.64 |
|
| 2016 |
Hibar DP, Westlye LT, van Erp TG, Rasmussen J, Leonardo CD, Faskowitz J, Haukvik UK, Hartberg CB, Doan NT, Agartz I, Dale AM, Gruber O, Krämer B, Trost S, Liberg B, ... ... Kahn RS, et al. Subcortical volumetric abnormalities in bipolar disorder. Molecular Psychiatry. PMID 26857596 DOI: 10.1038/Mp.2015.227 |
0.363 |
|
| 2016 |
Medema S, Mocking RJ, Koeter MW, Vaz FM, Meijer C, de Haan L, van Beveren NJ, Kahn R, de Haan L, van Os J, Wiersma D, Bruggeman R, Cahn W, Meijer C, et al. Levels of Red Blood Cell Fatty Acids in Patients With Psychosis, Their Unaffected Siblings, and Healthy Controls. Schizophrenia Bulletin. 42: 358-68. PMID 26385764 DOI: 10.1093/Schbul/Sbv133 |
0.346 |
|
| 2016 |
Collin G, Hilligers MHJ, Scholtens LH, Kahn RS, Heuvel MPVd. Rich club organization of the connectome in children at familial high risk for schizophrenia and bipolar disorder European Neuropsychopharmacology. 26. DOI: 10.1016/S0924-977X(16)31552-8 |
0.343 |
|
| 2016 |
Boks MP, Houtepen LC, He Y, Mierlo Hv, Kahn RS, Witte LDd, Vinkers CH. Association of DNA methylation marks in the stress response regulating gene KITLG to schizophrenia and bipolar disorder Psychoneuroendocrinology. 71: 37-37. DOI: 10.1016/J.Psyneuen.2016.07.099 |
0.352 |
|
| 2015 |
de Leeuw M, Bohlken MM, Mandl RC, Kahn RS, Vink M. Reduced fronto-striatal white matter integrity in schizophrenia patients and unaffected siblings: a DTI study. Npj Schizophrenia. 1: 15001. PMID 27336028 DOI: 10.1038/npjschz.2015.1 |
0.69 |
|
| 2015 |
Kahn RS, Sommer IE, Murray RM, Meyer-Lindenberg A, Weinberger DR, Cannon TD, O'Donovan M, Correll CU, Kane JM, van Os J, Insel TR. Schizophrenia. Nature Reviews. Disease Primers. 1: 15067. PMID 27189524 DOI: 10.1038/nrdp.2015.67 |
0.521 |
|
| 2015 |
Renes RA, Vink M, van der Weiden A, Prikken M, Koevoets MG, Kahn RS, Aarts H, van Haren NE. Impaired frontal processing during agency inferences in schizophrenia. Psychiatry Research. PMID 26776080 DOI: 10.1016/J.Pscychresns.2015.12.006 |
0.712 |
|
| 2015 |
Maat A, van Haren NE, Bartholomeusz CF, Kahn RS, Cahn W. Emotion recognition and theory of mind are related to gray matter volume of the prefrontal cortex in schizophrenia. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 26711688 DOI: 10.1016/J.Euroneuro.2015.12.013 |
0.447 |
|
| 2015 |
Volavka J, Van Dorn RA, Citrome L, Kahn RS, Fleischhacker WW, Czobor P. Hostility in schizophrenia: An integrated analysis of the combined Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and the European First Episode Schizophrenia Trial (EUFEST) studies. European Psychiatry : the Journal of the Association of European Psychiatrists. 31: 13-19. PMID 26657597 DOI: 10.1016/J.Eurpsy.2015.10.003 |
0.396 |
|
| 2015 |
van den Heuvel MP, Scholtens LH, de Reus MA, Kahn RS. Associated Microscale Spine Density and Macroscale Connectivity Disruptions in Schizophrenia. Biological Psychiatry. PMID 26632269 DOI: 10.1016/J.Biopsych.2015.10.005 |
0.437 |
|
| 2015 |
Vink M, de Leeuw M, Pouwels R, van den Munkhof HE, Kahn RS, Hillegers M. Diminishing striatal activation across adolescent development during reward anticipation in offspring of schizophrenia patients. Schizophrenia Research. PMID 26631365 DOI: 10.1016/J.Schres.2015.11.018 |
0.71 |
|
| 2015 |
Bohlken MM, Brouwer RM, Mandl RC, Van den Heuvel MP, Hedman AM, De Hert M, Cahn W, Kahn RS, Hulshoff Pol HE. Structural Brain Connectivity as a Genetic Marker for Schizophrenia. Jama Psychiatry. 1-9. PMID 26606729 DOI: 10.1001/Jamapsychiatry.2015.1925 |
0.408 |
|
| 2015 |
Vink M, de Leeuw M, Luykx JJ, van Eijk KR, van den Munkhof HE, van Buuren M, Kahn RS. DRD2 Schizophrenia-Risk Allele Is Associated With Impaired Striatal Functioning in Unaffected Siblings of Schizophrenia Patients. Schizophrenia Bulletin. PMID 26598739 DOI: 10.1093/Schbul/Sbv166 |
0.692 |
|
| 2015 |
Bootsman F, Brouwer RM, Kemner SM, Schnack HG, van der Schot AC, Vonk R, Hillegers MH, Boomsma DI, Hulshoff Pol HE, Nolen WA, Kahn RS, van Haren NE. Contribution of genes and unique environment to cross-sectional and longitudinal measures of subcortical volumes in bipolar disorder. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 26481908 DOI: 10.1016/J.Euroneuro.2015.09.023 |
0.353 |
|
| 2015 |
Collin G, van den Heuvel MP, Abramovic L, Vreeker A, de Reus MA, van Haren NE, Boks MP, Ophoff RA, Kahn RS. Brain network analysis reveals affected connectome structure in bipolar I disorder. Human Brain Mapping. PMID 26454006 DOI: 10.1002/Hbm.23017 |
0.377 |
|
| 2015 |
van Haren NE, Schnack HG, Koevoets MG, Cahn W, Hulshoff Pol HE, Kahn RS. Trajectories of subcortical volume change in schizophrenia: A 5-year follow-up. Schizophrenia Research. PMID 26439952 DOI: 10.1016/J.Schres.2015.09.027 |
0.434 |
|
| 2015 |
Bohlken MM, Brouwer RM, Mandl RC, Hedman AM, van den Heuvel MP, van Haren NE, Kahn RS, Hulshoff Pol HE. Topology of genetic associations between regional gray matter volume and intellectual ability: Evidence for a high capacity network. Neuroimage. 124: 1044-1053. PMID 26424180 DOI: 10.1016/J.Neuroimage.2015.09.046 |
0.328 |
|
| 2015 |
Kahn RS, Giannopoulou A. The safety, efficacy and tolerability of Abilify Maintena for the treatment of schizophrenia. Expert Review of Neurotherapeutics. 15: 969-81. PMID 26289486 DOI: 10.1586/14737175.2015.1070670 |
0.38 |
|
| 2015 |
Lee SH, Byrne EM, Hultman CM, Kähler A, Vinkhuyzen AA, Ripke S, Andreassen OA, Frisell T, Gusev A, Hu X, Karlsson R, Mantzioris VX, McGrath JJ, Mehta D, Stahl EA, ... ... Kahn RS, et al. New data and an old puzzle: the negative association between schizophrenia and rheumatoid arthritis. International Journal of Epidemiology. PMID 26286434 DOI: 10.1093/Ije/Dyv136 |
0.359 |
|
| 2015 |
Heering HD, Koevoets GJ, Koenders L, Machielsen MW, Meijer CJ, Kubota M, de Nijs J, Cahn W, Hulshoff Pol HE, de Haan L, Kahn RS, van Haren NE. Structural MRI Differences between Patients with and without First Rank Symptoms: A Delusion? Frontiers in Psychiatry. 6: 107. PMID 26283974 DOI: 10.3389/Fpsyt.2015.00107 |
0.373 |
|
| 2015 |
van Erp TG, Hibar DP, Rasmussen JM, Glahn DC, Pearlson GD, Andreassen OA, Agartz I, Westlye LT, Haukvik UK, Dale AM, Melle I, Hartberg CB, Gruber O, Kraemer B, Zilles D, ... ... Kahn RS, et al. Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium. Molecular Psychiatry. PMID 26283641 DOI: 10.1038/Mp.2015.118 |
0.673 |
|
| 2015 |
Toulopoulou T, van Haren N, Zhang X, Sham PC, Cherny SS, Campbell DD, Picchioni M, Murray R, Boomsma DI, Pol HH, Brouwer R, Schnack H, Fañanás L, Sauer H, Nenadic I, ... ... Kahn RS, et al. Reciprocal causation models of cognitive vs volumetric cerebral intermediate phenotypes for schizophrenia in a pan-European twin cohort. Molecular Psychiatry. PMID 26283640 DOI: 10.1038/Mp.2015.117 |
0.535 |
|
| 2015 |
Hedman AM, van Haren NE, van Baal GC, Brouwer RM, Brans RG, Schnack HG, Kahn RS, Hulshoff Pol HE. Heritability of cortical thickness changes over time in twin pairs discordant for schizophrenia. Schizophrenia Research. PMID 26215507 DOI: 10.1016/J.Schres.2015.06.021 |
0.429 |
|
| 2015 |
Emsley R, Asmal L, Chiliza B, du Plessis S, Carr J, Kidd M, Malhotra AK, Vink M, Kahn RS. Changes in brain regions associated with food-intake regulation, body mass and metabolic profiles during acute antipsychotic treatment in first-episode schizophrenia. Psychiatry Research. PMID 26184461 DOI: 10.1016/J.Pscychresns.2015.06.014 |
0.678 |
|
| 2015 |
Rösler L, Rolfs M, Van der Stigchel S, Neggers SF, Cahn W, Kahn RS, Thakkar KN. Failure to use corollary discharge to remap visual target locations is associated with psychotic symptom severity in schizophrenia. Journal of Neurophysiology. jn.00155.2015. PMID 26108951 DOI: 10.1152/Jn.00155.2015 |
0.325 |
|
| 2015 |
Kubota M, van Haren NE, Haijma SV, Schnack HG, Cahn W, Hulshoff Pol HE, Kahn RS. Association of IQ Changes and Progressive Brain Changes in Patients With Schizophrenia. Jama Psychiatry. PMID 26083394 DOI: 10.1001/Jamapsychiatry.2015.0712 |
0.421 |
|
| 2015 |
van Erp TG, Hibar DP, Rasmussen JM, Glahn DC, Pearlson GD, Andreassen OA, Agartz I, Westlye LT, Haukvik UK, Dale AM, Melle I, Hartberg CB, Gruber O, Kraemer B, Zilles D, ... ... Kahn RS, et al. Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium. Molecular Psychiatry. PMID 26033243 DOI: 10.1038/Mp.2015.63 |
0.672 |
|
| 2015 |
Czobor P, Van Dorn RA, Citrome L, Kahn RS, Fleischhacker WW, Volavka J. Treatment adherence in schizophrenia: A patient-level meta-analysis of combined CATIE and EUFEST studies. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 25: 1158-66. PMID 26004980 DOI: 10.1016/J.Euroneuro.2015.04.003 |
0.39 |
|
| 2015 |
de Witte LD, Hoffmann C, van Mierlo HC, Titulaer MJ, Kahn RS, Martinez-Martinez P. Absence of N-Methyl-D-Aspartate Receptor IgG Autoantibodies in Schizophrenia: The Importance of Cross-Validation Studies. Jama Psychiatry. 72: 731-3. PMID 25970159 DOI: 10.1001/Jamapsychiatry.2015.0526 |
0.334 |
|
| 2015 |
Vreeker A, van Bergen AH, Kahn RS. Cognitive enhancing agents in schizophrenia and bipolar disorder. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 25: 969-1002. PMID 25957798 DOI: 10.1016/J.Euroneuro.2015.04.014 |
0.402 |
|
| 2015 |
Pijnenborg GH, Timmerman ME, Derks EM, Fleischhacker WW, Kahn RS, Aleman A. Differential effects of antipsychotic drugs on insight in first episode schizophrenia: Data from the European First-Episode Schizophrenia Trial (EUFEST). European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 25: 808-16. PMID 25907250 DOI: 10.1016/J.Euroneuro.2015.02.012 |
0.423 |
|
| 2015 |
Arango C, Kapur S, Kahn RS. Going beyond "trial-and-error" in psychiatric treatments: OPTiMiSE-ing the treatment of first episode of schizophrenia. Schizophrenia Bulletin. 41: 546-8. PMID 25864201 DOI: 10.1093/Schbul/Sbv026 |
0.37 |
|
| 2015 |
Zandi T, Havenaar JM, Laan W, Kahn RS, Brink WV. Effects of a culturally sensitive assessment on symptom profiles in native Dutch and Moroccan patients with a first psychosis referral. Transcultural Psychiatry. PMID 25851336 DOI: 10.1177/1363461515577288 |
0.302 |
|
| 2015 |
Renes RA, van der Weiden A, Prikken M, Kahn RS, Aarts H, van Haren NE. Abnormalities in the experience of self-agency in schizophrenia: A replication study. Schizophrenia Research. 164: 210-3. PMID 25843918 DOI: 10.1016/J.Schres.2015.03.015 |
0.349 |
|
| 2015 |
Svatkova A, Mandl RC, Scheewe TW, Cahn W, Kahn RS, Hulshoff Pol HE. Physical Exercise Keeps the Brain Connected: Biking Increases White Matter Integrity in Patients With Schizophrenia and Healthy Controls. Schizophrenia Bulletin. 41: 869-78. PMID 25829377 DOI: 10.1093/Schbul/Sbv033 |
0.402 |
|
| 2015 |
Bossong MG, Mehta MA, van Berckel BN, Howes OD, Kahn RS, Stokes PR. Further human evidence for striatal dopamine release induced by administration of ∆9-tetrahydrocannabinol (THC): selectivity to limbic striatum. Psychopharmacology. 232: 2723-9. PMID 25801289 DOI: 10.1007/S00213-015-3915-0 |
0.355 |
|
| 2015 |
Dazzan P, Arango C, Fleischacker W, Galderisi S, Glenthøj B, Leucht S, Meyer-Lindenberg A, Kahn R, Rujescu D, Sommer I, Winter I, McGuire P. Magnetic resonance imaging and the prediction of outcome in first-episode schizophrenia: a review of current evidence and directions for future research. Schizophrenia Bulletin. 41: 574-83. PMID 25800248 DOI: 10.1093/Schbul/Sbv024 |
0.372 |
|
| 2015 |
Vorstman JA, Breetvelt EJ, Duijff SN, Eliez S, Schneider M, Jalbrzikowski M, Armando M, Vicari S, Shashi V, Hooper SR, Chow EW, Fung WL, Butcher NJ, Young DA, McDonald-McGinn DM, ... ... Kahn RS, et al. Cognitive decline preceding the onset of psychosis in patients with 22q11.2 deletion syndrome. Jama Psychiatry. 72: 377-85. PMID 25715178 DOI: 10.1001/Jamapsychiatry.2014.2671 |
0.33 |
|
| 2015 |
Vink M, Kleerekooper I, van den Wildenberg WP, Kahn RS. Impact of aging on frontostriatal reward processing. Human Brain Mapping. 36: 2305-17. PMID 25704624 DOI: 10.1002/Hbm.22771 |
0.64 |
|
| 2015 |
Vinkers CH, Joëls M, Milaneschi Y, Gerritsen L, Kahn RS, Penninx BW, Boks MP. Mineralocorticoid receptor haplotypes sex-dependently moderate depression susceptibility following childhood maltreatment. Psychoneuroendocrinology. 54: 90-102. PMID 25686805 DOI: 10.1016/J.Psyneuen.2015.01.018 |
0.546 |
|
| 2015 |
Schirmbeck F, Boyette LL, van der Valk R, Meijer C, Dingemans P, Van R, de Haan L, Kahn RS, de Haan L, van Os J, Wiersma D, Bruggeman R, Cahn W, Meijer C, et al. Relevance of Five-Factor Model personality traits for obsessive-compulsive symptoms in patients with psychotic disorders and their un-affected siblings. Psychiatry Research. 225: 464-70. PMID 25613659 DOI: 10.1016/J.Psychres.2014.11.066 |
0.338 |
|
| 2015 |
Hibar DP, Stein JL, Renteria ME, Arias-Vasquez A, Desrivières S, Jahanshad N, Toro R, Wittfeld K, Abramovic L, Andersson M, Aribisala BS, Armstrong NJ, Bernard M, Bohlken MM, Boks MP, ... ... Kahn RS, et al. Common genetic variants influence human subcortical brain structures. Nature. 520: 224-9. PMID 25607358 DOI: 10.1038/Nature14101 |
0.68 |
|
| 2015 |
Maat A, van Montfort SJ, de Nijs J, Derks EM, Kahn RS, Linszen DH, van Os J, Wiersma D, Bruggeman R, Cahn W, de Haan L, Krabbendam L, Myin-Germeys I. Emotion processing in schizophrenia is state and trait dependent. Schizophrenia Research. 161: 392-8. PMID 25543332 DOI: 10.1016/J.Schres.2014.11.027 |
0.386 |
|
| 2015 |
Mandl RC, Pasternak O, Cahn W, Kubicki M, Kahn RS, Shenton ME, Hulshoff Pol HE. Comparing free water imaging and magnetization transfer measurements in schizophrenia. Schizophrenia Research. 161: 126-32. PMID 25454797 DOI: 10.1016/J.Schres.2014.09.046 |
0.362 |
|
| 2015 |
Houtepen LC, Boks MP, Kahn RS, Joëls M, Vinkers CH. Antipsychotic use is associated with a blunted cortisol stress response: a study in euthymic bipolar disorder patients and their unaffected siblings. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 25: 77-84. PMID 25453485 DOI: 10.1016/J.Euroneuro.2014.10.005 |
0.591 |
|
| 2015 |
de Leeuw M, Kahn RS, Vink M. Fronto-striatal dysfunction during reward processing in unaffected siblings of schizophrenia patients. Schizophrenia Bulletin. 41: 94-103. PMID 25368371 DOI: 10.1093/Schbul/Sbu153 |
0.723 |
|
| 2015 |
Sommer IE, Kahn RS. The contribution of neuroimaging to understanding schizophrenia; past, present, and future. Schizophrenia Bulletin. 41: 1-3. PMID 25347988 DOI: 10.1093/Schbul/Sbu141 |
0.407 |
|
| 2015 |
Arango C, Kahn RS. More treatment for those most in need? A foregone conclusion? Schizophrenia Bulletin. 41: 26-7. PMID 25344948 DOI: 10.1093/Schbul/Sbu149 |
0.329 |
|
| 2015 |
Kennis M, Rademaker AR, van Rooij SJ, Kahn RS, Geuze E. Resting state functional connectivity of the anterior cingulate cortex in veterans with and without post-traumatic stress disorder. Human Brain Mapping. 36: 99-109. PMID 25137414 DOI: 10.1002/Hbm.22615 |
0.307 |
|
| 2015 |
Bootsman F, Brouwer RM, Schnack HG, van Baal GC, van der Schot AC, Vonk R, Hulshoff Pol HE, Nolen WA, Kahn RS, van Haren NE. Genetic and environmental influences on cortical surface area and cortical thickness in bipolar disorder. Psychological Medicine. 45: 193-204. PMID 25065711 DOI: 10.1017/S0033291714001251 |
0.311 |
|
| 2015 |
Kahn RS, Sommer IE. The neurobiology and treatment of first-episode schizophrenia. Molecular Psychiatry. 20: 84-97. PMID 25048005 DOI: 10.1038/Mp.2014.66 |
0.458 |
|
| 2015 |
van Rooij SJ, Rademaker AR, Kennis M, Vink M, Kahn RS, Geuze E. Neural correlates of trauma-unrelated emotional processing in war veterans with PTSD. Psychological Medicine. 45: 575-87. PMID 25036523 DOI: 10.1017/S0033291714001706 |
0.596 |
|
| 2015 |
van Erp TGM, Hibar DP, Rasmussen JM, Glahn DC, Pearlson GD, Andreassen OA, Agartz I, Westlye LT, Haukvik UK, Dale AM, Melle I, Hartberg CB, Gruber O, Kraemer B, Zilles D, ... ... Kahn RS, et al. Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium Molecular Psychiatry. DOI: 10.1038/mp.2015.118 |
0.329 |
|
| 2015 |
Hillegers M, De Jong A, Vink M, Pouwels R, Vleeschouwer M, Van Haren N, Kahn R. S.22.01 Clinical and neuro-imaging characteristics of child and adolescent bipolar and schizophrenia offspring European Neuropsychopharmacology. 25: S142. DOI: 10.1016/S0924-977X(15)30101-2 |
0.67 |
|
| 2015 |
Pijnenborg G, Timmerman M, Derks E, Fleischhacker W, Kahn R, Aleman A. Do Antipsychotics Affect Insight in Psychosis Differentially? Data From the EUFEST Trial. European Psychiatry. 30: 239. DOI: 10.1016/S0924-9338(15)30194-2 |
0.399 |
|
| 2015 |
Cahn W, Bruggeman R, De Haan L, Kahn R, Myin-Germeys I, Van Os J. Long-term Outcome in Schizophrenia: a Six-year Follow-up in over 1000 Patients European Psychiatry. 30: 238. DOI: 10.1016/S0924-9338(15)30193-0 |
0.403 |
|
| 2014 |
Sommer IE, Kahn RS. Psychosis susceptibility syndrome: an alternative name for schizophrenia. The Lancet. Psychiatry. 1: 111. PMID 26360567 DOI: 10.1016/S2215-0366(14)70288-3 |
0.4 |
|
| 2014 |
Vonk R, van der Schot AC, van Baal GC, van Oel CJ, Nolen WA, Kahn RS. Dermatoglyphics in relation to brain volumes in twins concordant and discordant for bipolar disorder. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 24: 1885-95. PMID 25451699 DOI: 10.1016/J.Euroneuro.2014.09.010 |
0.345 |
|
| 2014 |
Toulopoulou T, van Haren N, Zhang X, Sham PC, Cherny SS, Campbell DD, Picchioni M, Murray R, Boomsma DI, Pol HH, Brouwer R, Schnack H, Fañanás L, Sauer H, Nenadic I, ... ... Kahn RS, et al. Reciprocal causation models of cognitive vs volumetric cerebral intermediate phenotypes for schizophrenia in a pan-European twin cohort. Molecular Psychiatry. PMID 25450228 DOI: 10.1038/Mp.2014.152 |
0.571 |
|
| 2014 |
Marsman A, Mandl RC, Klomp DW, Bohlken MM, Boer VO, Andreychenko A, Cahn W, Kahn RS, Luijten PR, Hulshoff Pol HE. GABA and glutamate in schizophrenia: a 7 T ¹H-MRS study. Neuroimage. Clinical. 6: 398-407. PMID 25379453 DOI: 10.1016/J.Nicl.2014.10.005 |
0.366 |
|
| 2014 |
Stringer S, Kahn RS, de Witte LD, Ophoff RA, Derks EM. Genetic liability for schizophrenia predicts risk of immune disorders. Schizophrenia Research. 159: 347-52. PMID 25266548 DOI: 10.1016/J.Schres.2014.09.004 |
0.38 |
|
| 2014 |
Meijer JH, van Harten P, Meijer CJ, Koeter MW, Bruggeman R, Cahn W, Kahn RS, de Haan L. Association between olfactory identification and parkinsonism in patients with non-affective psychosis. Early Intervention in Psychiatry. PMID 25234230 DOI: 10.1111/Eip.12183 |
0.418 |
|
| 2014 |
Rybakowski JK, Vansteelandt K, Remlinger-Molenda A, Fleischhacker WW, Kahn RS, Peuskens J. Extrapyramidal symptoms during treatment of first schizophrenia episode: results from EUFEST. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 24: 1500-5. PMID 25085534 DOI: 10.1016/J.Euroneuro.2014.07.001 |
0.39 |
|
| 2014 |
van Lutterveld R, van den Heuvel MP, Diederen KM, de Weijer AD, Begemann MJ, Brouwer RM, Daalman K, Blom JD, Kahn RS, Sommer IE. Cortical thickness in individuals with non-clinical and clinical psychotic symptoms. Brain : a Journal of Neurology. 137: 2664-9. PMID 24951640 DOI: 10.1093/Brain/Awu167 |
0.341 |
|
| 2014 |
van Rooij SJ, Rademaker AR, Kennis M, Vink M, Kahn RS, Geuze E. Impaired right inferior frontal gyrus response to contextual cues in male veterans with PTSD during response inhibition. Journal of Psychiatry & Neuroscience : Jpn. 39: 330-8. PMID 24886789 DOI: 10.1503/Jpn.130223 |
0.635 |
|
| 2014 |
Marques TR, Levine SZ, Reichenberg A, Kahn R, Derks EM, Fleischhacker WW, Rabinowitz J, Kapur S. How antipsychotics impact the different dimensions of Schizophrenia: a test of competing hypotheses. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 24: 1279-88. PMID 24862257 DOI: 10.1016/J.Euroneuro.2014.04.001 |
0.401 |
|
| 2014 |
Bohlken MM, Mandl RC, Brouwer RM, van den Heuvel MP, Hedman AM, Kahn RS, Hulshoff Pol HE. Heritability of structural brain network topology: a DTI study of 156 twins. Human Brain Mapping. 35: 5295-305. PMID 24845163 DOI: 10.1002/Hbm.22550 |
0.311 |
|
| 2014 |
Brouwer RM, Hedman AM, van Haren NE, Schnack HG, Brans RG, Smit DJ, Kahn RS, Boomsma DI, Hulshoff Pol HE. Heritability of brain volume change and its relation to intelligence. Neuroimage. 100: 676-83. PMID 24816534 DOI: 10.1016/J.Neuroimage.2014.04.072 |
0.319 |
|
| 2014 |
Vinkers CH, Joëls M, Milaneschi Y, Kahn RS, Penninx BW, Boks MP. Stress exposure across the life span cumulatively increases depression risk and is moderated by neuroticism. Depression and Anxiety. 31: 737-45. PMID 24753162 DOI: 10.1002/Da.22262 |
0.535 |
|
| 2014 |
de Witte L, Tomasik J, Schwarz E, Guest PC, Rahmoune H, Kahn RS, Bahn S. Cytokine alterations in first-episode schizophrenia patients before and after antipsychotic treatment. Schizophrenia Research. 154: 23-9. PMID 24582037 DOI: 10.1016/J.Schres.2014.02.005 |
0.356 |
|
| 2014 |
Vink M, Zandbelt BB, Gladwin T, Hillegers M, Hoogendam JM, van den Wildenberg WP, Du Plessis S, Kahn RS. Frontostriatal activity and connectivity increase during proactive inhibition across adolescence and early adulthood. Human Brain Mapping. 35: 4415-27. PMID 24532023 DOI: 10.1002/Hbm.22483 |
0.801 |
|
| 2014 |
Vink M, Derks JM, Hoogendam JM, Hillegers M, Kahn RS. Functional differences in emotion processing during adolescence and early adulthood. Neuroimage. 91: 70-6. PMID 24468408 DOI: 10.1016/J.Neuroimage.2014.01.035 |
0.647 |
|
| 2014 |
Maat A, Cahn W, Gijsman HJ, Hovens JE, Kahn RS, Aleman A. Open, randomized trial of the effects of aripiprazole versus risperidone on social cognition in schizophrenia. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 24: 575-84. PMID 24418213 DOI: 10.1016/J.Euroneuro.2013.12.009 |
0.312 |
|
| 2014 |
Thompson PM, Stein JL, Medland SE, Hibar DP, Vasquez AA, Renteria ME, Toro R, Jahanshad N, Schumann G, Franke B, Wright MJ, Martin NG, Agartz I, Alda M, Alhusaini S, ... ... Kahn RS, et al. The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data. Brain Imaging and Behavior. 8: 153-82. PMID 24399358 DOI: 10.1007/S11682-013-9269-5 |
0.768 |
|
| 2014 |
Brouwer RM, van Soelen IL, Swagerman SC, Schnack HG, Ehli EA, Kahn RS, Hulshoff Pol HE, Boomsma DI. Genetic associations between intelligence and cortical thickness emerge at the start of puberty. Human Brain Mapping. 35: 3760-73. PMID 24382822 DOI: 10.1002/Hbm.22435 |
0.301 |
|
| 2014 |
Schubart CD, Sommer IE, Fusar-Poli P, de Witte L, Kahn RS, Boks MP. Cannabidiol as a potential treatment for psychosis. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 24: 51-64. PMID 24309088 DOI: 10.1016/J.Euroneuro.2013.11.002 |
0.326 |
|
| 2014 |
Collin G, Kahn RS, de Reus MA, Cahn W, van den Heuvel MP. Impaired rich club connectivity in unaffected siblings of schizophrenia patients. Schizophrenia Bulletin. 40: 438-48. PMID 24298172 DOI: 10.1093/Schbul/Sbt162 |
0.473 |
|
| 2014 |
Sommer IE, van Westrhenen R, Begemann MJ, de Witte LD, Leucht S, Kahn RS. Efficacy of anti-inflammatory agents to improve symptoms in patients with schizophrenia: an update. Schizophrenia Bulletin. 40: 181-91. PMID 24106335 DOI: 10.1093/Schbul/Sbt139 |
0.369 |
|
| 2014 |
Bohlken MM, Brouwer RM, Mandl RC, van Haren NE, Brans RG, van Baal GC, de Geus EJ, Boomsma DI, Kahn RS, Hulshoff Pol HE. Genes contributing to subcortical volumes and intellectual ability implicate the thalamus. Human Brain Mapping. 35: 2632-42. PMID 24038793 DOI: 10.1002/Hbm.22356 |
0.329 |
|
| 2014 |
Schnack HG, Nieuwenhuis M, van Haren NE, Abramovic L, Scheewe TW, Brouwer RM, Hulshoff Pol HE, Kahn RS. Can structural MRI aid in clinical classification? A machine learning study in two independent samples of patients with schizophrenia, bipolar disorder and healthy subjects. Neuroimage. 84: 299-306. PMID 24004694 DOI: 10.1016/J.Neuroimage.2013.08.053 |
0.435 |
|
| 2014 |
Bramon E, Pirinen M, Strange A, Lin K, Freeman C, Bellenguez C, Su Z, Band G, Pearson R, Vukcevic D, Langford C, Deloukas P, Hunt S, ... ... Kahn RS, et al. A genome-wide association analysis of a broad psychosis phenotype identifies three loci for further investigation. Biological Psychiatry. 75: 386-97. PMID 23871474 DOI: 10.1016/J.Biopsych.2013.03.033 |
0.404 |
|
| 2014 |
Luykx JJ, Bakker SC, Lentjes E, Neeleman M, Strengman E, Mentink L, DeYoung J, de Jong S, Sul JH, Eskin E, van Eijk K, van Setten J, Buizer-Voskamp JE, Cantor RM, Lu A, ... ... Kahn RS, et al. Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid. Molecular Psychiatry. 19: 228-34. PMID 23319000 DOI: 10.1038/Mp.2012.183 |
0.316 |
|
| 2014 |
De Leeuw M, Bohlken M, Mandl R, Kahn R, Vink M. P.3.b.022 Fronto–striatal pathways among schizophrenia patients and their unaffected siblings European Neuropsychopharmacology. 24: S504. DOI: 10.1016/S0924-977X(14)70806-5 |
0.688 |
|
| 2014 |
Bossong M, Schubart C, Van Hell H, Iseger T, Van Saane W, Jager G, Van Osch P, Jansma J, Kahn R, Boks M, Ramsey N. P.1.i.012 Genetic modulation of acute effects of delta-9-tetrahydrocannabinol (THC) on resting state brain function European Neuropsychopharmacology. 24: S303-S304. DOI: 10.1016/S0924-977X(14)70481-X |
0.492 |
|
| 2014 |
Sommer I, Witte LDD, Westrhenen RV, Begemann M, Kahn RS. S.18.02 Anti-inflammatory strategies in the treatment of schizophrenia European Neuropsychopharmacology. 24. DOI: 10.1016/S0924-977X(14)70183-X |
0.343 |
|
| 2014 |
van Rooij S, Rademaker A, Kennis M, Vink M, Kahn R, Geuze E. P.4.001 Neural correlates of non-trauma related emotional processing in war veterans with posttraumatic stress disorder European Neuropsychopharmacology. 24: S81. DOI: 10.1016/S0924-977X(14)70091-4 |
0.613 |
|
| 2014 |
Svátková A, Mandl RC, Scheewe TW, Kahn R, Cahn W, Pol HEH. EPA-1717 – Effects of exercise therapy on white matter integrity in patients with schizophrenia and healthy controls- a longitudinal DTI study European Psychiatry. 29: 1. DOI: 10.1016/S0924-9338(14)78856-X |
0.367 |
|
| 2014 |
Van Lutterveld R, Van den Heuvel M, Diederen K, De Weijer A, Begemann M, Brouwer R, Daalman K, Blom J, Kahn R, Sommer I. EPA-1053 – Cortical thickness in individuals with nonclinical and clinical psychotic symptoms European Psychiatry. 29: 1. DOI: 10.1016/S0924-9338(14)78339-7 |
0.391 |
|
| 2014 |
Vinkers C, Houtepen L, Kahn R, Joels M, Boks M. EPA-0848 – Stress reactivity in euthymic bipolar patietns and their unaffected siblings European Psychiatry. 29: 1. DOI: 10.1016/S0924-9338(14)78185-4 |
0.301 |
|
| 2014 |
Emsley R, Asmal L, Ciliza B, Plessis Sd, Carr J, Kidd M, Vink M, Kahn R. Poster #T68 BRAIN SYSTEMS REGULATING FOOD-INTAKE AND BODY MASS CHANGES DURING ACUTE ANTIPSYCHOTIC TREATMENT IN FIRST-EPISODE SCHIZOPHRENIA Schizophrenia Research. 153. DOI: 10.1016/S0920-9964(14)70885-0 |
0.668 |
|
| 2014 |
Vink M, Pouwels R, Hillegers M, Kahn R. Poster #M72 DIFFERENTIAL DEVELOPMENT OF THE REWARD NETWORK IN ADOLESCENT OFFSPRING OF SCHIZOPHRENIA PATIENTS Schizophrenia Research. 153: S215-S216. DOI: 10.1016/S0920-9964(14)70622-X |
0.673 |
|
| 2014 |
Kubota M, van Haren NE, Cahn W, Kahn R. Poster #M55 DURATION OF ILLNESS ASSOCIATED WITH CORTICAL THICKNESS CHANGE IN SCHIZOPHRENIA: A LONGITUDINAL MRI STUDY Schizophrenia Research. 153: S209. DOI: 10.1016/S0920-9964(14)70605-X |
0.39 |
|
| 2014 |
Bohlken M, Mandl R, Brouwer R, Kahn R, Pol HH. Poster #M47 WHITE MATTER INTEGRITY AS A CANDIDATE ENDOPHENOTYPE FOR SCHIZOPHRENIA Schizophrenia Research. 153: S206. DOI: 10.1016/S0920-9964(14)70597-3 |
0.374 |
|
| 2014 |
Pouwels R, Kahn R, Hillegers M, Vink M. Poster #S106 IMPAIRED DEVELOPMENT OF BRAIN ACTIVATION UNDERLYING AFFECTIVE PROCESSING IN ADOLESCENTS AT FAMILIAL RISK FOR BIPOLAR DISORDER OR SCHIZOPHRENIA Schizophrenia Research. 153: S127. DOI: 10.1016/S0920-9964(14)70385-8 |
0.695 |
|
| 2014 |
van Haren NE, Haijma S, Cahn W, Kahn R. Poster #S71 CHANGE IN INTELLIGENCE IS ASSOCIATED WITH PROGRESSIVE GRAY MATTER LOSS IN THE EARLY YEARS OF SCHIZOPHRENIA Schizophrenia Research. 153: S114. DOI: 10.1016/S0920-9964(14)70350-0 |
0.384 |
|
| 2014 |
Schnack HG, Nieuwenhuis M, Haren NEMv, Cahn W, Kahn R, Pol HH. Poster #S65 CLASSIFICATION OF TWINS DISCORDANT FOR SCHIZOPHRENIA AND HEALTHY TWINS BASED ON THEIR STRUCTURAL MRI SCANS Schizophrenia Research. 153. DOI: 10.1016/S0920-9964(14)70344-5 |
0.384 |
|
| 2014 |
Maat A, Haren NEMv, Bartholomeusz C, Kahn R, Cahn W. Poster #S57 EMOTION RECOGNITION AND THEORY OF MIND ARE RELATED TO GRAY MATTER VOLUME OF THE PREFRONTAL CORTEX IN SCHIZOPHRENIA Schizophrenia Research. 153. DOI: 10.1016/S0920-9964(14)70336-6 |
0.359 |
|
| 2014 |
Williams JB, Kane JM, Kahn RS. SCHIZOPHRENIA RESEARCH: THE CHALLENGE OF MEASUREMENT VARIABILITY Schizophrenia Research. 153: S86. DOI: 10.1016/S0920-9964(14)70275-0 |
0.375 |
|
| 2014 |
Vorstman JAS, Kahn R. Twenty Years Of Research On The 22Q11.2 Deletion Syndrome And Schizophrenia: What Have We Learned So Far? Schizophrenia Research. 153. DOI: 10.1016/S0920-9964(14)70243-9 |
0.319 |
|
| 2014 |
de Leeuw M, Kahn R, Vink M. 5:30 PM REWARD PROCESSING IN UNAFFECTED SIBLINGS OF SCHIZOPHRENIA PATIENTS: AN FMRI STUDY Schizophrenia Research. 153: S64. DOI: 10.1016/S0920-9964(14)70206-3 |
0.706 |
|
| 2014 |
Marsman A, Mandl R, Klomp D, Bohlken M, Boer V, Andreychenko A, Cahn W, Kahn R, Luijten P, Pol HH. 5:15 Pm Gaba And Glutamate In Schizophrenia: A 7T 1H-Mrs Study Schizophrenia Research. 153. DOI: 10.1016/S0920-9964(14)70179-3 |
0.313 |
|
| 2014 |
Heuvel Mvd, Collin G, Hillegers M, Reus Md, Kahn W, Kahn R. 5:00 Pm Emerging Evidence Of Affected Anatomical Rich Club Hub Structure In Schizophrenia Patients, Their Healthy Siblings And Their Non-Affected Young Offspring Schizophrenia Research. 153. DOI: 10.1016/S0920-9964(14)70178-1 |
0.415 |
|
| 2014 |
Kahn RS, Cahn W, van Haren N, Haijma S, Hulshoff H. LONG TERM OUTCOME IN SCHIZOPHRENIA: A 6 YEAR FOLLOW UP IN OVER 1000 PATIENTS Schizophrenia Research. 153: S49-S50. DOI: 10.1016/S0920-9964(14)70163-X |
0.358 |
|
| 2014 |
Kahn RS, Vink M, Hillegers M, Vleeschouwer M. ABNORMALITIES IN REWARD PROCESSING IN OFFSPRING OF SCHIZOPHRENIA PATIENTS: FRONTAL-STRIATAL ABNORMALITIES AS A HIGH-RISK PHENOTYPE Schizophrenia Research. 153: S38. DOI: 10.1016/S0920-9964(14)70125-2 |
0.7 |
|
| 2014 |
Siever LJ, Kahn RS. NEW VISTAS IN DOPAMINE RECEPTOR RESEARCH: IMPLICATIONS FOR NOVEL THERAPIES IN SCHIZOPHRENIA Schizophrenia Research. 153: S5. DOI: 10.1016/S0920-9964(14)70016-7 |
0.348 |
|
| 2014 |
DeLisi L, Kahn R. Impact Of Genomics And Connectomics Approaches On Schizophrenia Research Schizophrenia Research. 153. DOI: 10.1016/S0920-9964(14)70004-0 |
0.345 |
|
| 2014 |
Kahn R. Social neuroscience in psychiatry: Of obvious relevance World Psychiatry. 13: 147-148. DOI: 10.1002/Wps.20124 |
0.408 |
|
| 2013 |
Jansma JM, van Raalten TR, Boessen R, Neggers SF, Jacobs RH, Kahn RS, Ramsey NF. fMRI guided rTMS evidence for reduced left prefrontal involvement after task practice. Plos One. 8: e80256. PMID 24376494 DOI: 10.1371/Journal.Pone.0080256 |
0.525 |
|
| 2013 |
Hoogendam JM, Kahn RS, Hillegers MH, van Buuren M, Vink M. Different developmental trajectories for anticipation and receipt of reward during adolescence. Developmental Cognitive Neuroscience. 6: 113-24. PMID 24055865 DOI: 10.1016/J.Dcn.2013.08.004 |
0.633 |
|
| 2013 |
de Leeuw M, Kahn RS, Zandbelt BB, Widschwendter CG, Vink M. Working memory and default mode network abnormalities in unaffected siblings of schizophrenia patients. Schizophrenia Research. 150: 555-62. PMID 24051015 DOI: 10.1016/J.Schres.2013.08.016 |
0.815 |
|
| 2013 |
Marder SR, Alphs L, Anghelescu IG, Arango C, Barnes TR, Caers I, Daniel DG, Dunayevich E, Fleischhacker WW, Garibaldi G, Green MF, Harvey PD, Kahn RS, Kane JM, Keefe RS, et al. Issues and perspectives in designing clinical trials for negative symptoms in schizophrenia. Schizophrenia Research. 150: 328-33. PMID 24028744 DOI: 10.1016/J.Schres.2013.07.058 |
0.309 |
|
| 2013 |
Bossong MG, Jansma JM, van Hell HH, Jager G, Kahn RS, Ramsey NF. Default mode network in the effects of Δ9-Tetrahydrocannabinol (THC) on human executive function. Plos One. 8: e70074. PMID 23936144 DOI: 10.1371/Journal.Pone.0070074 |
0.565 |
|
| 2013 |
Lee SH, Ripke S, Neale BM, Faraone SV, Purcell SM, Perlis RH, Mowry BJ, Thapar A, Goddard ME, Witte JS, Absher D, Agartz I, Akil H, Amin F, ... ... Kahn RS, et al. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nature Genetics. 45: 984-94. PMID 23933821 DOI: 10.1038/Ng.2711 |
0.321 |
|
| 2013 |
Bossong MG, van Hell HH, Jager G, Kahn RS, Ramsey NF, Jansma JM. The endocannabinoid system and emotional processing: a pharmacological fMRI study with ∆9-tetrahydrocannabinol. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 1687-97. PMID 23928295 DOI: 10.1016/J.Euroneuro.2013.06.009 |
0.51 |
|
| 2013 |
Kahn RS, Keefe RS. Schizophrenia is a cognitive illness: time for a change in focus. Jama Psychiatry. 70: 1107-12. PMID 23925787 DOI: 10.1001/Jamapsychiatry.2013.155 |
0.375 |
|
| 2013 |
Mandl RC, Brouwer RM, Cahn W, Kahn RS, Hulshoff Pol HE. Family-wise automatic classification in schizophrenia. Schizophrenia Research. 149: 108-11. PMID 23876264 DOI: 10.1016/J.Schres.2013.07.002 |
0.31 |
|
| 2013 |
Malchow B, Reich-Erkelenz D, Oertel-Knöchel V, Keller K, Hasan A, Schmitt A, Scheewe TW, Cahn W, Kahn RS, Falkai P. The effects of physical exercise in schizophrenia and affective disorders. European Archives of Psychiatry and Clinical Neuroscience. 263: 451-67. PMID 23873090 DOI: 10.1007/S00406-013-0423-2 |
0.342 |
|
| 2013 |
Brouwer A, Luykx JJ, van Boxmeer L, Bakker SC, Kahn RS. NMDA-receptor coagonists in serum, plasma, and cerebrospinal fluid of schizophrenia patients: a meta-analysis of case-control studies. Neuroscience and Biobehavioral Reviews. 37: 1587-96. PMID 23792047 DOI: 10.1016/J.Neubiorev.2013.06.007 |
0.334 |
|
| 2013 |
van den Heuvel MP, Sporns O, Collin G, Scheewe T, Mandl RC, Cahn W, Goñi J, Hulshoff Pol HE, Kahn RS. Abnormal rich club organization and functional brain dynamics in schizophrenia. Jama Psychiatry. 70: 783-92. PMID 23739835 DOI: 10.1001/Jamapsychiatry.2013.1328 |
0.42 |
|
| 2013 |
Kahn RS. Finally: a focus on cognition in schizophrenia. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 779-80. PMID 23684112 DOI: 10.1016/J.Euroneuro.2013.04.005 |
0.382 |
|
| 2013 |
Riecher-Rössler A, Rybakowski JK, Pflueger MO, Beyrau R, Kahn RS, Malik P, Fleischhacker WW. Hyperprolactinemia in antipsychotic-naive patients with first-episode psychosis. Psychological Medicine. 43: 2571-82. PMID 23590895 DOI: 10.1017/S0033291713000226 |
0.387 |
|
| 2013 |
Wobrock T, Falkai P, Schneider-Axmann T, Hasan A, Galderisi S, Davidson M, Kahn RS, Derks EM, Boter H, Rybakowski JK, Libiger J, Dollfus S, López-Ibor JJ, Peuskens J, Hranov LG, et al. Comorbid substance abuse in first-episode schizophrenia: effects on cognition and psychopathology in the EUFEST study. Schizophrenia Research. 147: 132-9. PMID 23537477 DOI: 10.1016/J.Schres.2013.03.001 |
0.436 |
|
| 2013 |
Hedman AM, van Haren NE, van Baal CG, Kahn RS, Hulshoff Pol HE. IQ change over time in schizophrenia and healthy individuals: a meta-analysis. Schizophrenia Research. 146: 201-8. PMID 23490758 DOI: 10.1016/J.Schres.2013.01.027 |
0.443 |
|
| 2013 |
Diederen KM, Charbonnier L, Neggers SF, van Lutterveld R, Daalman K, Slotema CW, Kahn RS, Sommer IE. Reproducibility of brain activation during auditory verbal hallucinations. Schizophrenia Research. 146: 320-5. PMID 23465967 DOI: 10.1016/J.Schres.2013.01.025 |
0.303 |
|
| 2013 |
Jansma JM, van Hell HH, Vanderschuren LJ, Bossong MG, Jager G, Kahn RS, Ramsey NF. THC reduces the anticipatory nucleus accumbens response to reward in subjects with a nicotine addiction. Translational Psychiatry. 3: e234. PMID 23443360 DOI: 10.1038/Tp.2013.6 |
0.49 |
|
| 2013 |
Czobor P, Volavka J, Derks EM, Bitter I, Libiger J, Kahn RS, Fleischhacker WW. Insight and hostility as predictors and correlates of nonadherence in the European First Episode Schizophrenia Trial. Journal of Clinical Psychopharmacology. 33: 258-61. PMID 23422388 DOI: 10.1097/Jcp.0B013E3182856886 |
0.401 |
|
| 2013 |
van Scheltinga AF, Bakker SC, van Haren NE, Derks EM, Buizer-Voskamp JE, Cahn W, Ripke S, Ophoff RA, Kahn RS. Schizophrenia genetic variants are not associated with intelligence. Psychological Medicine. 43: 2563-70. PMID 23410598 DOI: 10.1017/S0033291713000196 |
0.44 |
|
| 2013 |
Terwisscha van Scheltinga AF, Bakker SC, Kahn RS, Kas MJ. Fibroblast growth factors in neurodevelopment and psychopathology. The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry. 19: 479-94. PMID 23343917 DOI: 10.1177/1073858412472399 |
0.324 |
|
| 2013 |
Fleischhacker WW, Siu CO, Bodén R, Pappadopulos E, Karayal ON, Kahn RS. Metabolic risk factors in first-episode schizophrenia: baseline prevalence and course analysed from the European First-Episode Schizophrenia Trial. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 16: 987-95. PMID 23253821 DOI: 10.1017/S1461145712001241 |
0.38 |
|
| 2013 |
van Welie H, Derks EM, Verweij KH, de Valk HW, Kahn RS, Cahn W. The prevalence of diabetes mellitus is increased in relatives of patients with a non-affective psychotic disorder. Schizophrenia Research. 143: 354-7. PMID 23245702 DOI: 10.1016/J.Schres.2012.11.011 |
0.348 |
|
| 2013 |
Diederen KM, Neggers SF, de Weijer AD, van Lutterveld R, Daalman K, Eickhoff SB, Clos M, Kahn RS, Sommer IE. Aberrant resting-state connectivity in non-psychotic individuals with auditory hallucinations. Psychological Medicine. 43: 1685-96. PMID 23199762 DOI: 10.1017/S0033291712002541 |
0.366 |
|
| 2013 |
Vorstman JA, Anney RJ, Derks EM, Gallagher L, Gill M, de Jonge MV, van Engeland H, Kahn RS, Ophoff RA. No evidence that common genetic risk variation is shared between schizophrenia and autism. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 162: 55-60. PMID 23193033 DOI: 10.1002/Ajmg.B.32121 |
0.41 |
|
| 2013 |
Renes RA, Vermeulen L, Kahn RS, Aarts H, van Haren NE. Abnormalities in the establishment of feeling of self-agency in schizophrenia. Schizophrenia Research. 143: 50-4. PMID 23178108 DOI: 10.1016/J.Schres.2012.10.024 |
0.363 |
|
| 2013 |
Scheewe TW, Backx FJ, Takken T, Jörg F, van Strater AC, Kroes AG, Kahn RS, Cahn W. Exercise therapy improves mental and physical health in schizophrenia: a randomised controlled trial. Acta Psychiatrica Scandinavica. 127: 464-73. PMID 23106093 DOI: 10.1111/Acps.12029 |
0.322 |
|
| 2013 |
Zandbelt BB, Bloemendaal M, Hoogendam JM, Kahn RS, Vink M. Transcranial magnetic stimulation and functional MRI reveal cortical and subcortical interactions during stop-signal response inhibition. Journal of Cognitive Neuroscience. 25: 157-74. PMID 23066733 DOI: 10.1162/Jocn_A_00309 |
0.78 |
|
| 2013 |
Haijma SV, Van Haren N, Cahn W, Koolschijn PC, Hulshoff Pol HE, Kahn RS. Brain volumes in schizophrenia: a meta-analysis in over 18 000 subjects. Schizophrenia Bulletin. 39: 1129-38. PMID 23042112 DOI: 10.1093/Schbul/Sbs118 |
0.428 |
|
| 2013 |
Terwisscha van Scheltinga AF, Bakker SC, van Haren NE, Derks EM, Buizer-Voskamp JE, Boos HB, Cahn W, Hulshoff Pol HE, Ripke S, Ophoff RA, Kahn RS. Genetic schizophrenia risk variants jointly modulate total brain and white matter volume. Biological Psychiatry. 73: 525-31. PMID 23039932 DOI: 10.1016/J.Biopsych.2012.08.017 |
0.429 |
|
| 2013 |
Collin G, de Reus MA, Cahn W, Hulshoff Pol HE, Kahn RS, van den Heuvel MP. Disturbed grey matter coupling in schizophrenia. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 46-54. PMID 23036782 DOI: 10.1016/J.Euroneuro.2012.09.001 |
0.427 |
|
| 2013 |
Van Haren NE, Cahn W, Hulshoff Pol HE, Kahn RS. Confounders of excessive brain volume loss in schizophrenia. Neuroscience and Biobehavioral Reviews. 37: 2418-23. PMID 23000300 DOI: 10.1016/J.Neubiorev.2012.09.006 |
0.424 |
|
| 2013 |
Scheewe TW, van Haren NE, Sarkisyan G, Schnack HG, Brouwer RM, de Glint M, Hulshoff Pol HE, Backx FJ, Kahn RS, Cahn W. Exercise therapy, cardiorespiratory fitness and their effect on brain volumes: a randomised controlled trial in patients with schizophrenia and healthy controls. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 675-85. PMID 22981376 DOI: 10.1016/J.Euroneuro.2012.08.008 |
0.39 |
|
| 2013 |
Boos HB, Mandl RC, van Haren NE, Cahn W, van Baal GC, Kahn RS, Hulshoff Pol HE. Tract-based diffusion tensor imaging in patients with schizophrenia and their non-psychotic siblings. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 295-304. PMID 22841128 DOI: 10.1016/J.Euroneuro.2012.05.015 |
0.439 |
|
| 2013 |
van den Heuvel MP, van Soelen IL, Stam CJ, Kahn RS, Boomsma DI, Hulshoff Pol HE. Genetic control of functional brain network efficiency in children. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 19-23. PMID 22819192 DOI: 10.1016/J.Euroneuro.2012.06.007 |
0.32 |
|
| 2013 |
van Liempt S, Arends J, Cluitmans PJ, Westenberg HG, Kahn RS, Vermetten E. Sympathetic activity and hypothalamo-pituitary-adrenal axis activity during sleep in post-traumatic stress disorder: a study assessing polysomnography with simultaneous blood sampling. Psychoneuroendocrinology. 38: 155-65. PMID 22776420 DOI: 10.1016/J.Psyneuen.2012.05.015 |
0.527 |
|
| 2013 |
Galderisi S, Mucci A, Bitter I, Libiger J, Bucci P, Fleischhacker WW, Kahn RS. Persistent negative symptoms in first episode patients with schizophrenia: results from the European First Episode Schizophrenia Trial. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 196-204. PMID 22647933 DOI: 10.1016/J.Euroneuro.2012.04.019 |
0.383 |
|
| 2013 |
Mandl RC, Rais M, van Baal GC, van Haren NE, Cahn W, Kahn RS, Hulshoff Pol HE. Altered white matter connectivity in never-medicated patients with schizophrenia. Human Brain Mapping. 34: 2353-65. PMID 22461372 DOI: 10.1002/Hbm.22075 |
0.393 |
|
| 2013 |
Sommer IE, de Kort GA, Meijering AL, Dazzan P, Hulshoff Pol HE, Kahn RS, van Haren NE. How frequent are radiological abnormalities in patients with psychosis? A review of 1379 MRI scans. Schizophrenia Bulletin. 39: 815-9. PMID 22416264 DOI: 10.1093/Schbul/Sbs037 |
0.35 |
|
| 2013 |
Zandbelt BB, Bloemendaal M, Neggers SF, Kahn RS, Vink M. Expectations and violations: delineating the neural network of proactive inhibitory control. Human Brain Mapping. 34: 2015-24. PMID 22359406 DOI: 10.1002/Hbm.22047 |
0.775 |
|
| 2013 |
Howes OD, Shotbolt P, Bloomfield M, Daalman K, Demjaha A, Diederen KM, Ibrahim K, Kim E, McGuire P, Kahn RS, Sommer IE. Dopaminergic function in the psychosis spectrum: an [18F]-DOPA imaging study in healthy individuals with auditory hallucinations. Schizophrenia Bulletin. 39: 807-14. PMID 22282457 DOI: 10.1093/Schbul/Sbr195 |
0.318 |
|
| 2013 |
van Soelen IL, Brouwer RM, van Baal GC, Schnack HG, Peper JS, Chen L, Kahn RS, Boomsma DI, Hulshoff Pol HE. Heritability of volumetric brain changes and height in children entering puberty. Human Brain Mapping. 34: 713-25. PMID 22140022 DOI: 10.1002/Hbm.21468 |
0.303 |
|
| 2013 |
de Weijer AD, Neggers SF, Diederen KM, Mandl RC, Kahn RS, Hulshoff Pol HE, Sommer IE. Aberrations in the arcuate fasciculus are associated with auditory verbal hallucinations in psychotic and in non-psychotic individuals. Human Brain Mapping. 34: 626-34. PMID 22109992 DOI: 10.1002/Hbm.21463 |
0.412 |
|
| 2013 |
Marsman A, van den Heuvel MP, Klomp DW, Kahn RS, Luijten PR, Hulshoff Pol HE. Glutamate in schizophrenia: a focused review and meta-analysis of ¹H-MRS studies. Schizophrenia Bulletin. 39: 120-9. PMID 21746807 DOI: 10.1093/Schbul/Sbr069 |
0.423 |
|
| 2013 |
Maat A, Cahn W, Gijsman HJ, Hovens JE, Kahn RS, Aleman A. Poster sessionsP.1.g. Basic and clinical neuroscience – NeuropharmacologyP.1.g.024 Open, randomized trial of the effects of aripiprazole versus risperidone on social cognition in schizophrenia European Neuropsychopharmacology. 23. DOI: 10.1016/S0924-977X(13)70311-0 |
0.303 |
|
| 2013 |
De Leeuw M, Kahn R, Vink M. S.07.07 Reward processing in unaffected siblings of schizophrenia patients: a functional magnetic resonance imaging study European Neuropsychopharmacology. 23: S122. DOI: 10.1016/S0924-977X(13)70151-2 |
0.685 |
|
| 2013 |
Doef TFvd, Yaqub M, Bossong MG, Boellaard R, Windhorst AD, Lammertsma AA, Kahn RS, Berckel BNMv. P.4.032 Neuroinflammation in temporal cortex in schizophrenia patients European Neuropsychopharmacology. 23. DOI: 10.1016/S0924-977X(13)70106-8 |
0.404 |
|
| 2013 |
de Leeuw M, Vink M, Kahn R. P.4.006 Reward processing in unaffected siblings of schizophrenia patients: a functional magnetic resonance imaging study European Neuropsychopharmacology. 23: S72-S73. DOI: 10.1016/S0924-977X(13)70081-6 |
0.61 |
|
| 2012 |
van Buuren M, Vink M, Kahn RS. Default-mode network dysfunction and self-referential processing in healthy siblings of schizophrenia patients. Schizophrenia Research. 142: 237-43. PMID 23099059 DOI: 10.1016/J.Schres.2012.09.017 |
0.705 |
|
| 2012 |
van der Kemp WJ, Klomp DW, Kahn RS, Luijten PR, Hulshoff Pol HE. A meta-analysis of the polyunsaturated fatty acid composition of erythrocyte membranes in schizophrenia. Schizophrenia Research. 141: 153-61. PMID 22981812 DOI: 10.1016/J.Schres.2012.08.014 |
0.391 |
|
| 2012 |
He Y, Yu Z, Giegling I, Xie L, Hartmann AM, Prehn C, Adamski J, Kahn R, Li Y, Illig T, Wang-Sattler R, Rujescu D. Schizophrenia shows a unique metabolomics signature in plasma Translational Psychiatry. 2. PMID 22892715 DOI: 10.1038/Tp.2012.76 |
0.426 |
|
| 2012 |
van Soelen IL, Brouwer RM, Peper JS, van Leeuwen M, Koenis MM, van Beijsterveldt TC, Swagerman SC, Kahn RS, Hulshoff Pol HE, Boomsma DI. Brain SCALE: brain structure and cognition: an adolescent longitudinal twin study into the genetic etiology of individual differences. Twin Research and Human Genetics : the Official Journal of the International Society For Twin Studies. 15: 453-67. PMID 22856378 DOI: 10.1017/Thg.2012.4 |
0.318 |
|
| 2012 |
van Lutterveld R, Hillebrand A, Diederen KM, Daalman K, Kahn RS, Stam CJ, Sommer IE. Oscillatory cortical network involved in auditory verbal hallucinations in schizophrenia. Plos One. 7: e41149. PMID 22844436 DOI: 10.1371/Journal.Pone.0041149 |
0.399 |
|
| 2012 |
Geyer MA, Olivier B, Joëls M, Kahn RS. From antipsychotic to anti-schizophrenia drugs: role of animal models. Trends in Pharmacological Sciences. 33: 515-21. PMID 22810174 DOI: 10.1016/J.Tips.2012.06.006 |
0.377 |
|
| 2012 |
de Jong S, Boks MP, Fuller TF, Strengman E, Janson E, de Kovel CG, Ori AP, Vi N, Mulder F, Blom JD, Glenthøj B, Schubart CD, Cahn W, Kahn RS, Horvath S, et al. A gene co-expression network in whole blood of schizophrenia patients is independent of antipsychotic-use and enriched for brain-expressed genes. Plos One. 7: e39498. PMID 22761806 DOI: 10.1371/Journal.Pone.0039498 |
0.407 |
|
| 2012 |
Derks EM, Vorstman JA, Ripke S, Kahn RS, Ophoff RA. Investigation of the genetic association between quantitative measures of psychosis and schizophrenia: a polygenic risk score analysis. Plos One. 7: e37852. PMID 22761660 DOI: 10.1371/Journal.Pone.0037852 |
0.414 |
|
| 2012 |
Hedman AM, van Haren NE, van Baal GC, Brans RG, Hijman R, Kahn RS, Hulshoff Pol HE. Is there change in intelligence quotient in chronically ill schizophrenia patients? A longitudinal study in twins discordant for schizophrenia. Psychological Medicine. 42: 2535-41. PMID 22717138 DOI: 10.1017/S0033291712000694 |
0.433 |
|
| 2012 |
Rybakowski JK, Vansteelandt K, Szafranski T, Thys E, Jarema M, Wolfgang Fleischhacker W, Kahn RS, Peuskens J. Treatment of depression in first episode of schizophrenia: results from EUFEST. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 22: 875-82. PMID 22627166 DOI: 10.1016/J.Euroneuro.2012.04.001 |
0.353 |
|
| 2012 |
Terwisscha van Scheltinga A, Bakker S, van Haren N, Buizer-Voskamp J, Boos H, Vorstman J, Cahn W, Hulshoff Pol H, Ophoff R, Kahn R. Association study of copy number variants with brain volume in schizophrenia patients and healthy controls. Psychiatry Research. 200: 1011-3. PMID 22551941 DOI: 10.1016/J.Psychres.2012.04.007 |
0.454 |
|
| 2012 |
Fleischhacker WW, Derks E, Kahn RS. Interpreting treatment trials in schizophrenia patients: lessons learned from EUFEST. Schizophrenia Research. 138: 39-40. PMID 22542244 DOI: 10.1016/J.Schres.2012.03.027 |
0.348 |
|
| 2012 |
Collin G, Derks EM, van Haren NE, Schnack HG, Hulshoff Pol HE, Kahn RS, Cahn W. Symptom dimensions are associated with progressive brain volume changes in schizophrenia. Schizophrenia Research. 138: 171-6. PMID 22534419 DOI: 10.1016/J.Schres.2012.03.036 |
0.432 |
|
| 2012 |
Scheewe TW, Takken T, Kahn RS, Cahn W, Backx FJ. Effects of exercise therapy on cardiorespiratory fitness in patients with schizophrenia. Medicine and Science in Sports and Exercise. 44: 1834-42. PMID 22525773 DOI: 10.1249/Mss.0B013E318258E120 |
0.323 |
|
| 2012 |
Nieuwenhuis M, van Haren NE, Hulshoff Pol HE, Cahn W, Kahn RS, Schnack HG. Classification of schizophrenia patients and healthy controls from structural MRI scans in two large independent samples. Neuroimage. 61: 606-12. PMID 22507227 DOI: 10.1016/J.Neuroimage.2012.03.079 |
0.386 |
|
| 2012 |
Stein JL, Medland SE, Vasquez AA, Hibar DP, Senstad RE, Winkler AM, Toro R, Appel K, Bartecek R, Bergmann Ø, Bernard M, Brown AA, Cannon DM, Chakravarty MM, Christoforou A, ... ... Kahn RS, et al. Identification of common variants associated with human hippocampal and intracranial volumes. Nature Genetics. 44: 552-61. PMID 22504417 DOI: 10.1038/Ng.2250 |
0.764 |
|
| 2012 |
Hulshoff Pol HE, van Baal GC, Schnack HG, Brans RG, van der Schot AC, Brouwer RM, van Haren NE, Lepage C, Collins DL, Evans AC, Boomsma DI, Nolen W, Kahn RS. Overlapping and segregating structural brain abnormalities in twins with schizophrenia or bipolar disorder. Archives of General Psychiatry. 69: 349-59. PMID 22474104 DOI: 10.1001/Archgenpsychiatry.2011.1615 |
0.459 |
|
| 2012 |
de Jong S, van Eijk KR, Zeegers DW, Strengman E, Janson E, Veldink JH, van den Berg LH, Cahn W, Kahn RS, Boks MP, Ophoff RA. Expression QTL analysis of top loci from GWAS meta-analysis highlights additional schizophrenia candidate genes. European Journal of Human Genetics : Ejhg. 20: 1004-8. PMID 22433715 DOI: 10.1038/Ejhg.2012.38 |
0.41 |
|
| 2012 |
Dollfus S, Alary M, Razafimandimby A, Prelipceanu D, Rybakowski JK, Davidson M, Galderisi S, Libiger J, Hranov LG, Hummer M, Boter H, Peuskens J, Kahn RS, Fleischhacker WW. Familial sinistrality and handedness in patients with first episode schizophrenia: the EUFEST study. Laterality. 17: 217-24. PMID 22385143 DOI: 10.1080/1357650X.2011.558510 |
0.405 |
|
| 2012 |
Rais M, Cahn W, Schnack HG, Hulshoff Pol HE, Kahn RS, van Haren NE. Brain volume reductions in medication-naive patients with schizophrenia in relation to intelligence quotient. Psychological Medicine. 42: 1847-56. PMID 22357376 DOI: 10.1017/S0033291712000098 |
0.416 |
|
| 2012 |
van Haren NE, Rijsdijk F, Schnack HG, Picchioni MM, Toulopoulou T, Weisbrod M, Sauer H, van Erp TG, Cannon TD, Huttunen MO, Boomsma DI, Hulshoff Pol HE, Murray RM, Kahn RS. The genetic and environmental determinants of the association between brain abnormalities and schizophrenia: the schizophrenia twins and relatives consortium. Biological Psychiatry. 71: 915-21. PMID 22341827 DOI: 10.1016/J.Biopsych.2012.01.010 |
0.717 |
|
| 2012 |
Bossong MG, Jansma JM, van Hell HH, Jager G, Oudman E, Saliasi E, Kahn RS, Ramsey NF. Effects of δ9-tetrahydrocannabinol on human working memory function. Biological Psychiatry. 71: 693-9. PMID 22341370 DOI: 10.1016/J.Biopsych.2012.01.008 |
0.604 |
|
| 2012 |
van Dijk D, Koeter MW, Hijman R, Kahn RS, van den Brink W. Effect of cannabis use on the course of schizophrenia in male patients: a prospective cohort study. Schizophrenia Research. 137: 50-7. PMID 22313726 DOI: 10.1016/J.Schres.2012.01.016 |
0.414 |
|
| 2012 |
Luykx JJ, Bakker SC, Lentjes E, Boks MP, van Geloven N, Eijkemans MJ, Janson E, Strengman E, de Lepper AM, Westenberg H, Klopper KE, Hoorn HJ, Gelissen HP, Jordan J, Tolenaar NM, ... ... Kahn RS, et al. Season of sampling and season of birth influence serotonin metabolite levels in human cerebrospinal fluid. Plos One. 7: e30497. PMID 22312427 DOI: 10.1371/Journal.Pone.0030497 |
0.542 |
|
| 2012 |
Aukes MF, Laan W, Termorshuizen F, Buizer-Voskamp JE, Hennekam EA, Smeets HM, Ophoff RA, Boks MP, Kahn RS. Familial clustering of schizophrenia, bipolar disorder, and major depressive disorder. Genetics in Medicine : Official Journal of the American College of Medical Genetics. 14: 338-41. PMID 22241106 DOI: 10.1016/Gim.2011.16 |
0.339 |
|
| 2012 |
Sommer IE, de Witte L, Begemann M, Kahn RS. Nonsteroidal anti-inflammatory drugs in schizophrenia: ready for practice or a good start? A meta-analysis. The Journal of Clinical Psychiatry. 73: 414-9. PMID 22225599 DOI: 10.4088/Jcp.10R06823 |
0.415 |
|
| 2012 |
Vonk R, van der Schot AC, van Baal GC, van Oel CJ, Nolen WA, Kahn RS. Premorbid school performance in twins concordant and discordant for bipolar disorder. Journal of Affective Disorders. 136: 294-303. PMID 22166398 DOI: 10.1016/J.Jad.2011.11.034 |
0.31 |
|
| 2012 |
Landolt K, Rössler W, Burns T, Ajdacic-Gross V, Galderisi S, Libiger J, Naber D, Derks EM, Kahn RS, Fleischhacker WW. Unmet needs in patients with first-episode schizophrenia: a longitudinal perspective. Psychological Medicine. 42: 1461-73. PMID 22099529 DOI: 10.1017/S0033291711002406 |
0.377 |
|
| 2012 |
Bossong MG, Jager G, van Hell HH, Zuurman L, Jansma JM, Mehta MA, van Gerven JM, Kahn RS, Ramsey NF. Effects of Δ9-tetrahydrocannabinol administration on human encoding and recall memory function: a pharmacological FMRI study. Journal of Cognitive Neuroscience. 24: 588-99. PMID 22066583 DOI: 10.1162/Jocn_A_00156 |
0.522 |
|
| 2012 |
van Hell HH, Jager G, Bossong MG, Brouwer A, Jansma JM, Zuurman L, van Gerven J, Kahn RS, Ramsey NF. Involvement of the endocannabinoid system in reward processing in the human brain. Psychopharmacology. 219: 981-90. PMID 21822593 DOI: 10.1007/S00213-011-2428-8 |
0.526 |
|
| 2012 |
Machielsen M, Beduin AS, Dekker N, Kahn RS, Linszen DH, van Os J, Wiersma D, Bruggeman R, Cahn W, de Haan L, Krabbendam L, Myin-Germeys I. Differences in craving for cannabis between schizophrenia patients using risperidone, olanzapine or clozapine. Journal of Psychopharmacology (Oxford, England). 26: 189-95. PMID 21768161 DOI: 10.1177/0269881111408957 |
0.337 |
|
| 2012 |
van Rijn S, Swaab H, Baas D, de Haan E, Kahn RS, Aleman A. Neural systems for social cognition in Klinefelter syndrome (47,XXY): evidence from fMRI. Social Cognitive and Affective Neuroscience. 7: 689-97. PMID 21737434 DOI: 10.1093/Scan/Nsr041 |
0.329 |
|
| 2012 |
Klomp A, Koolschijn PC, Hulshoff Pol HE, Kahn RS, Haren NE. Hypothalamus and pituitary volume in schizophrenia: a structural MRI study. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 15: 281-8. PMID 21733239 DOI: 10.1017/S1461145711000794 |
0.411 |
|
| 2012 |
van Haren NE, Cahn W, Hulshoff Pol HE, Kahn RS. The course of brain abnormalities in schizophrenia: can we slow the progression? Journal of Psychopharmacology (Oxford, England). 26: 8-14. PMID 21730018 DOI: 10.1177/0269881111408964 |
0.428 |
|
| 2012 |
Diederen KM, Daalman K, de Weijer AD, Neggers SF, van Gastel W, Blom JD, Kahn RS, Sommer IE. Auditory hallucinations elicit similar brain activation in psychotic and nonpsychotic individuals. Schizophrenia Bulletin. 38: 1074-82. PMID 21527413 DOI: 10.1093/Schbul/Sbr033 |
0.395 |
|
| 2012 |
Boos HB, Cahn W, van Haren NE, Derks EM, Brouwer RM, Schnack HG, Hulshoff Pol HE, Kahn RS. Focal and global brain measurements in siblings of patients with schizophrenia. Schizophrenia Bulletin. 38: 814-25. PMID 21242319 DOI: 10.1093/Schbul/Sbq147 |
0.461 |
|
| 2012 |
Ziermans TB, Schothorst PF, Schnack HG, Koolschijn PC, Kahn RS, van Engeland H, Durston S. Progressive structural brain changes during development of psychosis. Schizophrenia Bulletin. 38: 519-30. PMID 20929968 DOI: 10.1093/Schbul/Sbq113 |
0.375 |
|
| 2012 |
van Venrooij JA, Fluitman SB, Lijmer JG, Kavelaars A, Heijnen CJ, Westenberg HG, Kahn RS, Gispen-de Wied CC. Impaired neuroendocrine and immune response to acute stress in medication-naive patients with a first episode of psychosis. Schizophrenia Bulletin. 38: 272-9. PMID 20558533 DOI: 10.1093/Schbul/Sbq062 |
0.589 |
|
| 2012 |
Leeuw Md, Vink M, Kahn RS. Reward processing in unaffected siblings of schizophrenia patients: an fMRI study F1000research. 3. DOI: 10.7490/F1000Research.1092030.1 |
0.699 |
|
| 2012 |
van Dijk D, Koeter MW, Hijman R, Kahn RS, van den Brink W. Poster #252 EFFECT OF CANNABIS USE ON THE COURSE OF SCHIZOPHRENIA IN MALE PATIENTS: A PROSPECTIVE COHORT STUDY Schizophrenia Research. 136: S372. DOI: 10.1016/S0920-9964(12)71084-8 |
0.411 |
|
| 2012 |
Hedman AM, van Haren NE, van Baal CG, Kahn RS, Pol HEH. Poster #137 A META-ANALYSIS OF IQ CHANGE IN SCHIZOPHRENIA AND HEALTHY INDIVIDUALS Schizophrenia Research. 136: S329. DOI: 10.1016/S0920-9964(12)70969-6 |
0.411 |
|
| 2012 |
Vorstman l, Anney R, Derks E, Gallagher L, Gill M, Jonge Md, Engeland Hv, Kahn R, Ophoff R. Poster #112 NO EVIDENCE THAT COMMON GENETIC RISK VARIANTS ARE SHARED BETWEEN SCHIZOPHRENIA AND AUTISM Schizophrenia Research. 136. DOI: 10.1016/S0920-9964(12)70945-3 |
0.371 |
|
| 2012 |
van Haren NE, Schnack HG, Cahn W, Pol HEH, Kahn RS. Poster #53 CORTICAL THICKNESS AND CORTICAL SURFACE IN SCHIZOPHRENIA: TWO DISTINCT BUT RELEVANT PROCESSES? Schizophrenia Research. 136: S299-S300. DOI: 10.1016/S0920-9964(12)70886-1 |
0.363 |
|
| 2012 |
Mandl RCW, Rais M, Baal GCv, Haren Nv, Cairn W, Kahn RS, Pol HEH. Poster #46 ALTERED WHITE MATTER CONNECTIONS IN NEVER-MEDICATED PATIENTS WITH SCHIZOPHRENIA Schizophrenia Research. 136. DOI: 10.1016/S0920-9964(12)70879-4 |
0.391 |
|
| 2012 |
Vink M, Zandbelt BB, van Buuren M, Kahn RS. Poster #36 REDUCED PROACTIVE INHIBITORY CONTROL IN SCHIZOPHRENIA PATIENTS AND THEIR UNAFFECTED SIBLINGS Schizophrenia Research. 136: S293-S294. DOI: 10.1016/S0920-9964(12)70869-1 |
0.808 |
|
| 2012 |
Renes RA, Vermeulen L, Kahn RS, Aarts H, van Haren NE. Poster #162 DISTURBED SELF-AGENCY IN SCHIZOPHRENIA DUE TO ABNORMAL IMPLICIT (BUT NOT EXPLICIT) PROCESSING OF ACTION-OUTCOME INFORMATION Schizophrenia Research. 136: S244. DOI: 10.1016/S0920-9964(12)70734-X |
0.359 |
|
| 2012 |
Nieuwenhuis M, Haren NEv, Pol HEH, Cahn W, Kahn RS, Schnack HG. Poster #56 CLASSIFICATION OF SCHIZOPHRENIA PATIENTS AND HEALTHY CONTROLS FROM STRUCTURAL MRI SCANS VERIFIED IN TWO LARGE INDEPENDENT SAMPLES Schizophrenia Research. 136. DOI: 10.1016/S0920-9964(12)70628-X |
0.404 |
|
| 2012 |
Collin G, Van den Heuvel MP, De Reus MA, Boos HB, Calm W, Pol HEH, Kahn RS. Poster #48 FRONTOSTRIATAL DEPENDENCY IN GREY MATTER VOLUME IS REDUCED IN SCHIZOPHRENIA Schizophrenia Research. 136: S202-S203. DOI: 10.1016/S0920-9964(12)70620-5 |
0.418 |
|
| 2012 |
Breetvelt EJ, Aukes MF, Boks MP, Kahn RS, Ophoff RA. Poster #106 IN A NORMAL POPULATION SAMPLE SCHIZOPHRENIA ASSOCIATED COPY NUMBER VARIATIONS IN GENOMIC REGIONS 1Q21.1, 15Q11.2 ARE MORE FREQUENT IN FEMALE AND ARE ASSOCIATED WITH LOWER SOCIOECONOMIC STATUS, OBESITY AND HIGHER CHOLESTEROL LEVELS Schizophrenia Research. 136: S129-S130. DOI: 10.1016/S0920-9964(12)70421-8 |
0.306 |
|
| 2012 |
Bergen AHv, Termorshuizen F, Smeets HM, Sommer IE, Kahn RS, Boks MPM. Poster #95 IS CLOZAPINE TREATMENT ASSOCIATED WITH LOWER MORTALITY RATES IN SCHIZOPHRENIA? PRELIMINARY EVIDENCE FROM A REGISTER BASED STUDY Schizophrenia Research. 136. DOI: 10.1016/S0920-9964(12)70410-3 |
0.354 |
|
| 2012 |
de Leeuw M, Vink M, Zandbelt BB, Kahn RS. Poster #22 HYPERACTIVATION IN WORKING MEMORY CIRCUITS IN SIBLINGS OF SCHIZOPHRENIA PATIENTS: AN FMRI STUDY Schizophrenia Research. 136: S99. DOI: 10.1016/S0920-9964(12)70338-9 |
0.799 |
|
| 2012 |
Collin G, Pol HEH, Haijma SV, Cahn W, Kahn RS, Heuvel MPVd. Poster #19 IMPAIRED CEREBELLAR FUNCTIONAL CONNECTIVITY IN SCHIZOPHRENIA PATIENTS AND THEIR HEALTHY SIBLINGS Schizophrenia Research. 136. DOI: 10.1016/S0920-9964(12)70335-3 |
0.433 |
|
| 2012 |
Sommer IE, Witte LDd, Begemann M, Kahn RS. 14:45 Non-Steroidal Anti-Inflammatory Drugs In Schizophrenia: Ready For Practice Or A Good Start? A Meta-Analysis Schizophrenia Research. 136. DOI: 10.1016/S0920-9964(12)70276-1 |
0.321 |
|
| 2012 |
van Scheltinga AT, Bakker S, van Haren N, Boos H, Caln W, Nothen M, Rietschel M, Cichon S, Pol HH, Ophoff R, Kahn R. 14:00 COMMON POLYGENIC VARIATION CONTRIBUTING TO SCHIZOPHRENIA RISK EXPLAINS VARIATION IN TOTAL BRAIN VOLUME Schizophrenia Research. 136: S72. DOI: 10.1016/S0920-9964(12)70264-5 |
0.413 |
|
| 2012 |
Kahn R. Effects Of Physical Exercise On Psychotic Symptoms, Cognition And Brain Structure: Results Of A Randomized Clinical Trial In Chronic Schizophrenia Schizophrenia Research. 136. DOI: 10.1016/S0920-9964(12)70206-2 |
0.341 |
|
| 2012 |
Kahn RS. WHY ANTIPSYCHOTICS ARE GOOD FOR THE BRAIN Schizophrenia Research. 136: S51. DOI: 10.1016/S0920-9964(12)70185-8 |
0.322 |
|
| 2012 |
Kahn RS. PROGRESSIVE CHANGESIN BRAIN STRUCTUREIN SCHIZOPHRENIA-CLINICAL OUTCOME, MEDICATION AND HERITABILITY Schizophrenia Research. 136: S19. DOI: 10.1016/S0920-9964(12)70066-X |
0.382 |
|
| 2012 |
Kahn R. Brain Changes In Schizophrenia And Bipolar Disorder: Is There A Genetic Overlap? Schizophrenia Research. 136. DOI: 10.1016/S0920-9964(12)70027-0 |
0.405 |
|
| 2011 |
Collin G, Hulshoff Pol HE, Haijma SV, Cahn W, Kahn RS, van den Heuvel MP. Impaired cerebellar functional connectivity in schizophrenia patients and their healthy siblings. Frontiers in Psychiatry. 2: 73. PMID 22203807 DOI: 10.3389/Fpsyt.2011.00073 |
0.474 |
|
| 2011 |
Boonstra G, Burger H, Grobbee DE, Kahn RS. Antipsychotic prophylaxis is needed after remission from a first psychotic episode in schizophrenia patients: results from an aborted randomised trial. International Journal of Psychiatry in Clinical Practice. 15: 128-34. PMID 22121861 DOI: 10.3109/13651501.2010.534801 |
0.312 |
|
| 2011 |
van den Heuvel MP, Kahn RS. Abnormal brain wiring as a pathogenetic mechanism in schizophrenia. Biological Psychiatry. 70: 1107-8. PMID 22115412 DOI: 10.1016/J.Biopsych.2011.10.020 |
0.429 |
|
| 2011 |
Zandi T, Havenaar JM, Laan W, Kahn RS, van den Brink W. Predictive validity of a culturally informed diagnosis of schizophrenia: a 30 month follow-up study with first episode psychosis. Schizophrenia Research. 133: 29-35. PMID 22019074 DOI: 10.1016/J.Schres.2011.09.024 |
0.405 |
|
| 2011 |
Kas MJ, Kahn RS, Collier DA, Waddington JL, Ekelund J, Porteous DJ, Schughart K, Hovatta I. Translational neuroscience of schizophrenia: seeking a meeting of minds between mouse and man. Science Translational Medicine. 3: 102mr3. PMID 21957171 DOI: 10.1126/Scitranslmed.3002917 |
0.366 |
|
| 2011 |
Zandbelt BB, van Buuren M, Kahn RS, Vink M. Reduced proactive inhibition in schizophrenia is related to corticostriatal dysfunction and poor working memory. Biological Psychiatry. 70: 1151-8. PMID 21903198 DOI: 10.1016/J.Biopsych.2011.07.028 |
0.817 |
|
| 2011 |
van Haren NE, Schnack HG, Cahn W, van den Heuvel MP, Lepage C, Collins L, Evans AC, Hulshoff Pol HE, Kahn RS. Changes in cortical thickness during the course of illness in schizophrenia. Archives of General Psychiatry. 68: 871-80. PMID 21893656 DOI: 10.1001/Archgenpsychiatry.2011.88 |
0.397 |
|
| 2011 |
Daalman K, van Zandvoort M, Bootsman F, Boks M, Kahn R, Sommer I. Auditory verbal hallucinations and cognitive functioning in healthy individuals. Schizophrenia Research. 132: 203-7. PMID 21839618 DOI: 10.1016/J.Schres.2011.07.013 |
0.356 |
|
| 2011 |
Boonstra G, Cahn W, Schnack HG, Hulshoff Pol HE, Minderhoud TC, Kahn RS, van Haren NE. Duration of untreated illness in schizophrenia is not associated with 5-year brain volume change. Schizophrenia Research. 132: 84-90. PMID 21835595 DOI: 10.1016/J.Schres.2011.07.018 |
0.384 |
|
| 2011 |
Volavka J, Czobor P, Derks EM, Bitter I, Libiger J, Kahn RS, Fleischhacker WW. Efficacy of antipsychotic drugs against hostility in the European First-Episode Schizophrenia Trial (EUFEST). The Journal of Clinical Psychiatry. 72: 955-61. PMID 21824456 DOI: 10.4088/Jcp.10M06529 |
0.414 |
|
| 2011 |
de Weijer AD, Mandl RC, Diederen KM, Neggers SF, Kahn RS, Hulshoff Pol HE, Sommer IE. Microstructural alterations of the arcuate fasciculus in schizophrenia patients with frequent auditory verbal hallucinations. Schizophrenia Research. 130: 68-77. PMID 21641775 DOI: 10.1016/J.Schres.2011.05.010 |
0.393 |
|
| 2011 |
van Hell HH, Bossong MG, Jager G, Kahn RS, Ramsey NF. Methods of the pharmacological imaging of the cannabinoid system (PhICS) study: towards understanding the role of the brain endocannabinoid system in human cognition. International Journal of Methods in Psychiatric Research. 20: 10-27. PMID 21574207 DOI: 10.1002/Mpr.327 |
0.542 |
|
| 2011 |
van Buuren M, Vink M, Rapcencu AE, Kahn RS. Exaggerated brain activation during emotion processing in unaffected siblings of patients with schizophrenia. Biological Psychiatry. 70: 81-7. PMID 21531384 DOI: 10.1016/J.Biopsych.2011.03.011 |
0.706 |
|
| 2011 |
Malik P, Kemmler G, Hummer M, Riecher-Roessler A, Kahn RS, Fleischhacker WW. Sexual dysfunction in first-episode schizophrenia patients: results from European First Episode Schizophrenia Trial. Journal of Clinical Psychopharmacology. 31: 274-80. PMID 21508850 DOI: 10.1097/Jcp.0B013E3182199Bcc |
0.415 |
|
| 2011 |
van Veelen NM, Vink M, Ramsey NF, van Buuren M, Hoogendam JM, Kahn RS. Prefrontal lobe dysfunction predicts treatment response in medication-naive first-episode schizophrenia. Schizophrenia Research. 129: 156-62. PMID 21497488 DOI: 10.1016/J.Schres.2011.03.026 |
0.754 |
|
| 2011 |
Buizer-Voskamp JE, Laan W, Staal WG, Hennekam EA, Aukes MF, Termorshuizen F, Kahn RS, Boks MP, Ophoff RA. Paternal age and psychiatric disorders: findings from a Dutch population registry. Schizophrenia Research. 129: 128-32. PMID 21489755 DOI: 10.1016/J.Schres.2011.03.021 |
0.624 |
|
| 2011 |
van Hell HH, Bossong MG, Jager G, Kristo G, van Osch MJ, Zelaya F, Kahn RS, Ramsey NF. Evidence for involvement of the insula in the psychotropic effects of THC in humans: a double-blind, randomized pharmacological MRI study. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 14: 1377-88. PMID 21489346 DOI: 10.1017/S1461145711000526 |
0.555 |
|
| 2011 |
Daalman K, Boks MP, Diederen KM, de Weijer AD, Blom JD, Kahn RS, Sommer IE. The same or different? A phenomenological comparison of auditory verbal hallucinations in healthy and psychotic individuals. The Journal of Clinical Psychiatry. 72: 320-5. PMID 21450152 DOI: 10.4088/Jcp.09M05797Yel |
0.351 |
|
| 2011 |
Koning JP, Tenback DE, Kahn RS, Vollema MG, Cahn W, van Harten PN. Movement disorders are associated with schizotypy in unaffected siblings of patients with non-affective psychosis. Psychological Medicine. 41: 2141-7. PMID 21426602 DOI: 10.1017/S0033291711000389 |
0.37 |
|
| 2011 |
Boonstra G, van Haren NE, Schnack HG, Cahn W, Burger H, Boersma M, de Kroon B, Grobbee DE, Hulshoff Pol HE, Kahn RS. Brain volume changes after withdrawal of atypical antipsychotics in patients with first-episode schizophrenia. Journal of Clinical Psychopharmacology. 31: 146-53. PMID 21346618 DOI: 10.1097/Jcp.0B013E31820E3F58 |
0.428 |
|
| 2011 |
Koning JP, Kahn RS, Tenback DE, van Schelven LJ, van Harten PN. Movement disorders in nonpsychotic siblings of patients with nonaffective psychosis. Psychiatry Research. 188: 133-7. PMID 21277026 DOI: 10.1016/J.Psychres.2011.01.005 |
0.355 |
|
| 2011 |
van Veelen NM, Vink M, Ramsey NF, Sommer IE, van Buuren M, Hoogendam JM, Kahn RS. Reduced language lateralization in first-episode medication-naive schizophrenia. Schizophrenia Research. 127: 195-201. PMID 21237617 DOI: 10.1016/J.Schres.2010.12.013 |
0.736 |
|
| 2011 |
Zandi T, Havenaar JM, Kahn RS, van den Brink W. Incidence of schizophrenia among Moroccan immigrants to The Netherlands. Response to letter written by Selten et al. Schizophrenia Research. 128: 173-4. PMID 21146960 DOI: 10.1016/J.Schres.2010.11.010 |
0.329 |
|
| 2011 |
Kahn RS, Linszen DH, Van Os J, Wiersma D, Bruggeman R, Cahn W, De Haan L, Krabbendam L, Myin-Germeys I. Evidence that familial liability for psychosis is expressed as differential sensitivity to cannabis: An analysis of patient-sibling and sibling-control pairs Archives of General Psychiatry. 68: 138-147. PMID 20921112 DOI: 10.1001/Archgenpsychiatry.2010.132 |
0.319 |
|
| 2011 |
Magnée MJ, Kahn RS, Cahn W, Kemner C. More prolonged brain activity related to gaze cueing in schizophrenia. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 122: 506-11. PMID 20702135 DOI: 10.1016/J.Clinph.2010.07.014 |
0.389 |
|
| 2011 |
Vorstman JA, van Daalen E, Jalali GR, Schmidt ER, Pasterkamp RJ, de Jonge M, Hennekam EA, Janson E, Staal WG, van der Zwaag B, Burbach JP, Kahn RS, Emanuel BS, van Engeland H, Ophoff RA. A double hit implicates DIAPH3 as an autism risk gene. Molecular Psychiatry. 16: 442-51. PMID 20308993 DOI: 10.1038/Mp.2010.26 |
0.625 |
|
| 2011 |
van Hell H, Jansma J, Bossong M, Kahn R, Ramsey N. P.6.c.005 Endocannabinoid involvement in brain reward processing in nicotine addiction European Neuropsychopharmacology. 21: S578. DOI: 10.1016/S0924-977X(11)70945-2 |
0.473 |
|
| 2011 |
van Hell H, Jansma J, Bossong M, Jager G, Noorman K, Kahn R, Ramsey N. P.1.e.031 Endocannabinoids may not be involved in response inhibition in humans European Neuropsychopharmacology. 21: S321. DOI: 10.1016/S0924-977X(11)70509-0 |
0.453 |
|
| 2011 |
Bossong M, Jansma J, van Hell H, Jager G, Kahn R, Ramsey N. P.1.e.007 The effects of delta9-tetrahydrocannabinol (THC) on human brain function involved in emotional processing: a pharmacological fMRI study European Neuropsychopharmacology. 21: S307. DOI: 10.1016/S0924-977X(11)70485-0 |
0.491 |
|
| 2011 |
Bossong M, Jansma J, van Hell H, Jager G, Kahn R, Ramsey N. P.1.e.006 Involvement of the endocannabinoid system in executive function: a pharmacological fMRI study with delta9-tetrahydrocannabinol (THC) European Neuropsychopharmacology. 21: S306-S307. DOI: 10.1016/S0924-977X(11)70484-9 |
0.472 |
|
| 2011 |
Sommer I, Diederen K, Neggers S, Kahn R. S.09.05 fTMS and treatment of psychiatric disorders European Neuropsychopharmacology. 21: S201. DOI: 10.1016/S0924-977X(11)70277-2 |
0.314 |
|
| 2011 |
Hulshoff Pol H, Cahn W, Kahn R. S.01.05 Can neuroimaging in schizophrenia predict antipsychotic response European Neuropsychopharmacology. 21: S185-S186. DOI: 10.1016/S0924-977X(11)70238-3 |
0.395 |
|
| 2011 |
Scheewe TW, Haren NEMv, Takken T, Backx FJG, Kahn RS, Cahn W. P.4.013 Association between physical activity, fitness and global brain volumes in patients with schizophrenia and matched healthy controls European Neuropsychopharmacology. 21. DOI: 10.1016/S0924-977X(11)70102-X |
0.425 |
|
| 2011 |
Van Hell HH, Vink M, Ossewaarde L, Jager G, Kahn RS, Ramsey NF. Chronic effects of cannabis use on the human reward system: An fMRI study | Efectos crónicos del consumo de cannabis sobre el sistema de recompensa humano: un estudio de RMf Psiquiatria Biologica. 18: 45-54. DOI: 10.1016/J.Psiq.2011.08.003 |
0.672 |
|
| 2010 |
Diederen KM, De Weijer AD, Daalman K, Blom JD, Neggers SF, Kahn RS, Sommer IE. Decreased language lateralization is characteristic of psychosis, not auditory hallucinations. Brain : a Journal of Neurology. 133: 3734-44. PMID 21097491 DOI: 10.1093/Brain/Awq313 |
0.33 |
|
| 2010 |
Schnack HG, van Haren NE, Brouwer RM, van Baal GC, Picchioni M, Weisbrod M, Sauer H, Cannon TD, Huttunen M, Lepage C, Collins DL, Evans A, Murray RM, Kahn RS, Hulshoff Pol HE. Mapping reliability in multicenter MRI: voxel-based morphometry and cortical thickness. Human Brain Mapping. 31: 1967-82. PMID 21086550 DOI: 10.1002/Hbm.20991 |
0.451 |
|
| 2010 |
Van der Schot A, Kahn R, Ramsey N, Nolen W, Vink M. Trait and state dependent functional impairments in bipolar disorder. Psychiatry Research. 184: 135-42. PMID 21050725 DOI: 10.1016/J.Pscychresns.2010.07.009 |
0.728 |
|
| 2010 |
Rais M, van Haren NE, Cahn W, Schnack HG, Lepage C, Collins L, Evans AC, Hulshoff Pol HE, Kahn RS. Cannabis use and progressive cortical thickness loss in areas rich in CB1 receptors during the first five years of schizophrenia. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 20: 855-65. PMID 20863671 DOI: 10.1016/J.Euroneuro.2010.08.008 |
0.409 |
|
| 2010 |
van der Schot AC, Vonk R, Brouwer RM, van Baal GC, Brans RG, van Haren NE, Schnack HG, Boomsma DI, Nolen WA, Hulshoff Pol HE, Kahn RS. Genetic and environmental influences on focal brain density in bipolar disorder. Brain : a Journal of Neurology. 133: 3080-92. PMID 20837502 DOI: 10.1093/Brain/Awq236 |
0.363 |
|
| 2010 |
Grootens KP, van Veelen NM, Sitskoorn MM, Sabbe BG, Peuskens J, Buitelaar JK, Verkes RJ, Kahn RS. Effects on cognitive functioning after olanzapine-ziprasidone crossover in recent-onset schizophrenia. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 20: 907-12. PMID 20833514 DOI: 10.1016/J.Euroneuro.2010.08.003 |
0.386 |
|
| 2010 |
Vinkers CH, Mirza NR, Olivier B, Kahn RS. The inhibitory GABA system as a therapeutic target for cognitive symptoms in schizophrenia: investigational agents in the pipeline. Expert Opinion On Investigational Drugs. 19: 1217-33. PMID 20812877 DOI: 10.1517/13543784.2010.513382 |
0.38 |
|
| 2010 |
van Veelen NM, Vink M, Ramsey NF, Kahn RS. Left dorsolateral prefrontal cortex dysfunction in medication-naive schizophrenia. Schizophrenia Research. 123: 22-9. PMID 20724113 DOI: 10.1016/J.Schres.2010.07.004 |
0.767 |
|
| 2010 |
de Weijer AD, Mandl RC, Sommer IE, Vink M, Kahn RS, Neggers SF. Human fronto-tectal and fronto-striatal-tectal pathways activate differently during anti-saccades. Frontiers in Human Neuroscience. 4: 41. PMID 20631846 DOI: 10.3389/Fnhum.2010.00041 |
0.637 |
|
| 2010 |
Derks EM, Fleischhacker WW, Boter H, Peuskens J, Kahn RS. Antipsychotic drug treatment in first-episode psychosis: should patients be switched to a different antipsychotic drug after 2, 4, or 6 weeks of nonresponse? Journal of Clinical Psychopharmacology. 30: 176-80. PMID 20520291 DOI: 10.1097/Jcp.0B013E3181D2193C |
0.328 |
|
| 2010 |
van Lutterveld R, Oranje B, Kemner C, Abramovic L, Willems AE, Boks MP, Glenthøj BY, Kahn RS, Sommer IE. Increased psychophysiological parameters of attention in non-psychotic individuals with auditory verbal hallucinations. Schizophrenia Research. 121: 153-9. PMID 20494553 DOI: 10.1016/J.Schres.2010.04.017 |
0.424 |
|
| 2010 |
van Veelen NM, Grootens KP, Peuskens J, Sabbe BG, Salden ME, Verkes RJ, Kahn RS, Sitskoorn MM. Short term neurocognitive effects of treatment with ziprasidone and olanzapine in recent onset schizophrenia. Schizophrenia Research. 120: 191-8. PMID 20493663 DOI: 10.1016/J.Schres.2010.04.011 |
0.371 |
|
| 2010 |
Laan W, Grobbee DE, Selten JP, Heijnen CJ, Kahn RS, Burger H. Adjuvant aspirin therapy reduces symptoms of schizophrenia spectrum disorders: results from a randomized, double-blind, placebo-controlled trial. The Journal of Clinical Psychiatry. 71: 520-7. PMID 20492850 DOI: 10.4088/Jcp.09M05117Yel |
0.409 |
|
| 2010 |
Koolschijn PC, van Haren NE, Cahn W, Schnack HG, Janssen J, Klumpers F, Hulshoff Pol HE, Kahn RS. Hippocampal volume change in schizophrenia. The Journal of Clinical Psychiatry. 71: 737-44. PMID 20492835 DOI: 10.4088/Jcp.08M04574Yel |
0.434 |
|
| 2010 |
Breetvelt EJ, Boks MP, Numans ME, Selten JP, Sommer IE, Grobbee DE, Kahn RS, Geerlings MI. Schizophrenia risk factors constitute general risk factors for psychiatric symptoms in the population. Schizophrenia Research. 120: 184-90. PMID 20421160 DOI: 10.1016/J.Schres.2010.03.033 |
0.334 |
|
| 2010 |
Brans RG, Kahn RS, Schnack HG, van Baal GC, Posthuma D, van Haren NE, Lepage C, Lerch JP, Collins DL, Evans AC, Boomsma DI, Hulshoff Pol HE. Brain plasticity and intellectual ability are influenced by shared genes. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 5519-24. PMID 20410105 DOI: 10.1523/Jneurosci.5841-09.2010 |
0.328 |
|
| 2010 |
Zandi T, Havenaar JM, Smits M, Limburg-Okken AG, van Es H, Cahn W, Algra A, Kahn RS, van den Brink W. First contact incidence of psychotic disorders among native Dutch and Moroccan immigrants in the Netherlands: influence of diagnostic bias. Schizophrenia Research. 119: 27-33. PMID 20332065 DOI: 10.1016/J.Schres.2010.02.1059 |
0.331 |
|
| 2010 |
Van Haren NE, Koolschijn PC, Cahn W, Schnack HG, Hulshoff Pol HE, Kahn RS. Cigarette smoking and progressive brain volume loss in schizophrenia. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 20: 454-8. PMID 20227855 DOI: 10.1016/J.Euroneuro.2010.02.009 |
0.325 |
|
| 2010 |
Gaebel W, Riesbeck M, von Wilmsdorff M, Burns T, Derks EM, Kahn RS, Rössler W, Fleischhacker WW. Drug attitude as predictor for effectiveness in first-episode schizophrenia: Results of an open randomized trial (EUFEST). European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 20: 310-6. PMID 20202800 DOI: 10.1016/J.Euroneuro.2010.02.001 |
0.338 |
|
| 2010 |
Diederen KM, Neggers SF, Daalman K, Blom JD, Goekoop R, Kahn RS, Sommer IE. Deactivation of the parahippocampal gyrus preceding auditory hallucinations in schizophrenia. The American Journal of Psychiatry. 167: 427-35. PMID 20123912 DOI: 10.1176/Appi.Ajp.2009.09040456 |
0.36 |
|
| 2010 |
van Buuren M, Gladwin TE, Zandbelt BB, Kahn RS, Vink M. Reduced functional coupling in the default-mode network during self-referential processing. Human Brain Mapping. 31: 1117-27. PMID 20108218 DOI: 10.1002/Hbm.20920 |
0.774 |
|
| 2010 |
van Hell HH, Vink M, Ossewaarde L, Jager G, Kahn RS, Ramsey NF. Chronic effects of cannabis use on the human reward system: an fMRI study. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 20: 153-63. PMID 20061126 DOI: 10.1016/J.Euroneuro.2009.11.010 |
0.696 |
|
| 2010 |
Réthelyi JM, Bakker SC, Polgár P, Czobor P, Strengman E, Pásztor PI, Kahn RS, Bitter I. Association study of NRG1, DTNBP1, RGS4, G72/G30, and PIP5K2A with schizophrenia and symptom severity in a Hungarian sample. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 153: 792-801. PMID 19937977 DOI: 10.1002/Ajmg.B.31049 |
0.403 |
|
| 2010 |
Boter H, Derks EM, Fleischhacker WW, Davidson M, Kahn RS. Generalizability of the results of efficacy trials in first-episode schizophrenia: comparisons between subgroups of participants of the European First Episode Schizophrenia Trial (EUFEST). The Journal of Clinical Psychiatry. 71: 58-65. PMID 19852905 DOI: 10.4088/Jcp.08M04506Yel |
0.359 |
|
| 2010 |
Koolschijn PC, van Haren NE, Bakker SC, Hoogendoorn ML, Hulshoff Pol HE, Kahn RS. Effects of brain-derived neurotrophic factor Val66Met polymorphism on hippocampal volume change in schizophrenia. Hippocampus. 20: 1010-7. PMID 19714565 DOI: 10.1002/Hipo.20699 |
0.422 |
|
| 2010 |
Koolschijn PC, van Haren NE, Lensvelt-Mulders GJ, Hulshoff Pol HE, Kahn RS. Brain volume abnormalities in major depressive disorder: a meta-analysis of magnetic resonance imaging studies. Human Brain Mapping. 30: 3719-35. PMID 19441021 DOI: 10.1002/Hbm.20801 |
0.308 |
|
| 2010 |
Mandl RC, Schnack HG, Luigjes J, van den Heuvel MP, Cahn W, Kahn RS, Hulshoff Pol HE. Tract-based analysis of magnetization transfer ratio and diffusion tensor imaging of the frontal and frontotemporal connections in schizophrenia. Schizophrenia Bulletin. 36: 778-87. PMID 19042913 DOI: 10.1093/Schbul/Sbn161 |
0.421 |
|
| 2010 |
Koning JP, Tenback DE, van Os J, Aleman A, Kahn RS, van Harten PN. Dyskinesia and parkinsonism in antipsychotic-naive patients with schizophrenia, first-degree relatives and healthy controls: a meta-analysis. Schizophrenia Bulletin. 36: 723-31. PMID 18990712 DOI: 10.1093/Schbul/Sbn146 |
0.427 |
|
| 2010 |
Vink M, Zandbelt BB, Buuren Mv, Kahn RS. Stop-signal response inhibition deficits in schizophrenia patients and their unaffected siblings F1000research. 1. DOI: 10.7490/F1000Research.694.1 |
0.806 |
|
| 2010 |
Kahn R. Why treating early, treating well, and treating for life is important in schizophrenia Annals of General Psychiatry. 9. DOI: 10.1186/1744-859X-9-S1-S67 |
0.459 |
|
| 2010 |
Boos H, Cahn W, Van Haren N, Derks E, Brouwer R, Schnack H, Pol HH, Kahn R. P.1.e.018 Focal and global brain measurements in non-psychotic siblings of patients with schizophrenia European Neuropsychopharmacology. 20: S298-S299. DOI: 10.1016/S0924-977X(10)70397-7 |
0.417 |
|
| 2010 |
Jager G, van Hell H, Bossong M, Kristo G, Kahn R, Ramsey N. P.1.e.009 Delta9-THC induces non-specific psychotropic effects reflected in resting-state brain function: a pharmaco-imaging study European Neuropsychopharmacology. 20: S293. DOI: 10.1016/S0924-977X(10)70388-6 |
0.497 |
|
| 2010 |
Bossong M, van Hell H, Jager G, Oudman F, Kahn R, Ramsey N. P.1.e.005 Delta9-tetrahydrocannabinol (THC) impairs working memory system capacity: a pharmacological MRI study European Neuropsychopharmacology. 20: S290-S291. DOI: 10.1016/S0924-977X(10)70384-9 |
0.469 |
|
| 2010 |
Aukes M, Alizadeh B, Kemner C, Sitskoorn M, Ophoff R, Kahn R. S.24.02 Cognitive endophenotypes in schizophrenia European Neuropsychopharmacology. 20: S199-S200. DOI: 10.1016/S0924-977X(10)70218-2 |
0.377 |
|
| 2010 |
van Hell H, Jager G, Brouwer A, Bossong M, Kahn R, Ramsey N. P.3.024 Addiction proneness: contribution of the endocannabinoid system and reward processing European Neuropsychopharmacology. 20: S82. DOI: 10.1016/S0924-977X(10)70096-1 |
0.458 |
|
| 2010 |
Bossong M, van Hell H, Jager G, Oudman F, Kahn R, Ramsey N. P.3.003 Involvement of the endocannabinoid system in working memory: a pharmacological MRI study with delta9-THC European Neuropsychopharmacology. 20: S64. DOI: 10.1016/S0924-977X(10)70075-4 |
0.466 |
|
| 2010 |
van Haren N, Brans R, van Baal C, Schnack H, Kahn R, Hulshoff Pol H. S34-02 - Heritability of cortical thickness change over time in schizophrenia patients and their discordant co-twins European Psychiatry. 25: 96. DOI: 10.1016/S0924-9338(10)70096-1 |
0.438 |
|
| 2010 |
Marsman A, Van den Heuvel MP, Mandl RC, Kahn RS, Hulshoff Pol HE. GLUTAMATE IN SCHIZOPHRENIA - A REVIEW Schizophrenia Research. 117: 477. DOI: 10.1016/J.Schres.2010.02.899 |
0.378 |
|
| 2010 |
Widschwendter CG, Vink M, Zandbelt BB, Kahn RS. EVIDENCE FOR DECREASED FRONTO-STRIATAL FUNCTIONING IN SCHIZOPHRENIA DURING WORKING MEMORY Schizophrenia Research. 117: 476. DOI: 10.1016/J.Schres.2010.02.897 |
0.797 |
|
| 2010 |
Hoogendam JM, van Veelen NM, Vink M, Kahn RS. DECREASED LANGUAGE LATERALIZATION IN MEDICATION NAIVE SCHIZOPHRENIA Schizophrenia Research. 117: 475-476. DOI: 10.1016/J.Schres.2010.02.896 |
0.671 |
|
| 2010 |
Heuvel MPvd, Mandl RCW, Scheeuwe T, Kahn W, Kahn RS, Pol HEH. Functional Connectivity In Schizophrenia Schizophrenia Research. 117: 475-475. DOI: 10.1016/J.Schres.2010.02.894 |
0.413 |
|
| 2010 |
van Buuren M, Vink M, Kahn RS. ABERRANT COUPLING WITHIN THE DEFAULT-MODE NETWORK DURING SELF-REFERENTIAL PROCESSING IN HEALTHY SIBLINGS OF SCHIZOPHRENIA PATIENTS Schizophrenia Research. 117: 474. DOI: 10.1016/J.Schres.2010.02.893 |
0.676 |
|
| 2010 |
Ziermans TB, Schothorst PF, Schnack HG, Wit Sd, Kahn RS, Engeland Hv, Durston S. Progressive Structural Brain Changes Are Associated With Onset Of Psychosis Schizophrenia Research. 117: 464-464. DOI: 10.1016/J.Schres.2010.02.869 |
0.307 |
|
| 2010 |
Van Baal GCM, Pol HEH, Schnack HG, Brouwer RM, Brans RG, Kahn RS. CORTICAL THICKNESS IN SCHIZOPHRENIA AND BIPOLAR DISEASE: A TWIN MRI STUDY OF DISEASE-SPECIFIC AND COMORBID ENDOPHENOTYPES Schizophrenia Research. 117: 463. DOI: 10.1016/J.Schres.2010.02.867 |
0.378 |
|
| 2010 |
Schnack HG, Haren NEMv, Brouwer RM, Baal GCMv, Picchioni M, Weisbrod M, Sauer H, Cannon TD, Huttunen M, Lepage C, Collins DL, Evans A, Murray RM, Kahn RS, Pol HEH. Mapping Reliability Of Multicenter Mri: Cortical Thickness And Voxel-Based Morphometry Schizophrenia Research. 117: 461-461. DOI: 10.1016/J.Schres.2010.02.861 |
0.56 |
|
| 2010 |
Terwisscha van Schel AF, Bakker SC, van Haren NE, Pol HEH, Cahn W, Buizer-Voskamp JE, Gladwin TE, Vorstman JA, Ophoff RA, Kahn RS. ASSOCIATION STUDY OF CNVS WITH BRAIN VOLUME AND BRAIN VOLUME CHANGE OVER 5 YEARS IN SCHIZOPHRENIA PATIENTS AND HEALTHY CONTROLS Schizophrenia Research. 117: 454. DOI: 10.1016/J.Schres.2010.02.845 |
0.421 |
|
| 2010 |
Terwisscha van Schel AF, Bakker SC, van Haren NE, Pol HEH, Cahn W, Ophoff RA, Kahn RS. FIBROBLAST GROWTH FACTORS AND BRAIN VOLUME IN SCHIZOPHRENIA PATIENTS AND HEALTHY CONTROLS Schizophrenia Research. 117: 453. DOI: 10.1016/J.Schres.2010.02.844 |
0.419 |
|
| 2010 |
van Veelen NM, Vink M, Ramsey NF, Kahn RS. LEFT PRE-FRONTAL LOBE DYSFUNCTION IN MEDICATION NAIVE SCHIZOPHRENIA Schizophrenia Research. 117: 359. DOI: 10.1016/J.Schres.2010.02.631 |
0.735 |
|
| 2010 |
Aukes MF, Boks MP, Willems AE, van Lutterveld R, Sommer IE, Sitskoorn MM, Ophoff RA, Alizadeh BZ, Kahn RS. A GENOME-WIDE LINKAGE SCAN OF THETA BAND ACTIVITY AS AN ENDOPHENOTYPE FOR SCHIZOPHRENIA Schizophrenia Research. 117: 243-244. DOI: 10.1016/J.Schres.2010.02.370 |
0.401 |
|
| 2010 |
Boos HB, Cahn W, Van Haren NE, Derks EM, Brouwer RM, Schnack HG, Hulshoff Pol HE, Kahn RS. CORTICAL THICKNESS IN PATIENTS WITH SCHIZOPHRENIA AND THEIR SIBLINGS Schizophrenia Research. 117: 223. DOI: 10.1016/J.Schres.2010.02.322 |
0.419 |
|
| 2010 |
Boonstra G, van Haren NE, Schnack HG, Cahn W, Burger H, Boersma M, Grobbee DE, Hulshoff Pol HE, Kahn RS. BRAIN VOLUME CHANGES AFTER WITHDRAWAL OF ATYPICAL ANTIPSYCHOTICS IN FIRST-EPISODE SCHIZOPHRENIA PATIENTS Schizophrenia Research. 117: 223. DOI: 10.1016/J.Schres.2010.02.321 |
0.447 |
|
| 2010 |
Buizer-Voskamp JE, Laan W, Boks MPM, Staal WG, Hennekam EAM, Aukes MF, Kahn RS, Ophoff RA. Parental Age And The Risk Of Psychiatric Disorders Schizophrenia Research. 117: 194-194. DOI: 10.1016/J.Schres.2010.02.255 |
0.587 |
|
| 2010 |
van Haren NE, Rijsdijk F, Schnack H, Picchioni M, Weisbrod M, Sauer H, van Erp TG, Cannon TD, Boomsma D, Hulshoff Pol HE, Murray RM, Kahn RS. THE STAR CONSORTIUM: DO GENES OR ENVIRONMENT EXPLAIN THE ASSOCIATION BETWEEN SCHIZOPHRENIA AND A SMALLER BRAIN? Schizophrenia Research. 117: 171-172. DOI: 10.1016/J.Schres.2010.02.200 |
0.397 |
|
| 2010 |
Schnack HG, van Haren NE, Cahn W, Hulshoff Pol HE, Kahn RS. EXCESSIVE FOCAL BRAIN CHANGES IN SCHIZOPHRENIA: DIFFERENT AGE TRAJECTORIES MEASURED WITH LONGITUDINAL MRI Schizophrenia Research. 117: 533-534. DOI: 10.1016/J.Schres.2010.02.1049 |
0.411 |
|
| 2010 |
Somers M, Sommer IE, Kahn RS. OPTIMIZATION OF TREATMENT AND MANAGEMENT OF SCHIZOPHRENIA IN EUROPE: THE OPTIMISE TRIAL Schizophrenia Research. 117: 528-529. DOI: 10.1016/J.Schres.2010.02.1019 |
0.346 |
|
| 2010 |
van der Doef TF, Bossong MG, Boellaard R, Yaqub M, Kloet R, Schuitemaker A, van Haren N, Windhorst AD, Cahn W, Lammertsma AA, Kahn RS, van Berckel BN. Microglia activation in schizophrenia Neuroimage. 52: S145. DOI: 10.1016/J.Neuroimage.2010.04.119 |
0.418 |
|
| 2009 |
Galderisi S, Davidson M, Kahn RS, Mucci A, Boter H, Gheorghe MD, Rybakowski JK, Libiger J, Dollfus S, López-Ibor JJ, Peuskens J, Hranov LG, Fleischhacker WW. Correlates of cognitive impairment in first episode schizophrenia: the EUFEST study. Schizophrenia Research. 115: 104-14. PMID 19822407 DOI: 10.1016/J.Schres.2009.09.022 |
0.363 |
|
| 2009 |
Boter H, Peuskens J, Libiger J, Fleischhacker WW, Davidson M, Galderisi S, Kahn RS. Effectiveness of antipsychotics in first-episode schizophrenia and schizophreniform disorder on response and remission: an open randomized clinical trial (EUFEST). Schizophrenia Research. 115: 97-103. PMID 19819114 DOI: 10.1016/J.Schres.2009.09.019 |
0.333 |
|
| 2009 |
Kemner C, Foxe JJ, Tankink JE, Kahn RS, Lamme VA. Abnormal timing of visual feedback processing in young adults with schizophrenia. Neuropsychologia. 47: 3105-10. PMID 19631672 DOI: 10.1016/J.Neuropsychologia.2009.07.009 |
0.374 |
|
| 2009 |
Grootens KP, van Veelen NM, Peuskens J, Sabbe BG, Thys E, Buitelaar JK, Verkes RJ, Kahn RS. Ziprasidone vs olanzapine in recent-onset schizophrenia and schizoaffective disorder: results of an 8-week double-blind randomized controlled trial. Schizophrenia Bulletin. 37: 352-61. PMID 19542525 DOI: 10.1093/Schbul/Sbp037 |
0.424 |
|
| 2009 |
van 't Wout M, van Rijn S, Jellema T, Kahn RS, Aleman A. Deficits in implicit attention to social signals in schizophrenia and high risk groups: behavioural evidence from a new illusion. Plos One. 4: e5581. PMID 19440352 DOI: 10.1371/Journal.Pone.0005581 |
0.402 |
|
| 2009 |
Laan W, Smeets H, de Wit NJ, Kahn RS, Grobbee DE, Burger H. Glucocorticosteroids associated with a decreased risk of psychosis. Journal of Clinical Psychopharmacology. 29: 288-90. PMID 19440085 DOI: 10.1097/Jcp.0B013E3181A44575 |
0.334 |
|
| 2009 |
Terwisscha van Scheltinga AF, Bakker SC, Kahn RS. Fibroblast growth factors in schizophrenia. Schizophrenia Bulletin. 36: 1157-66. PMID 19429845 DOI: 10.1093/Schbul/Sbp033 |
0.402 |
|
| 2009 |
Magnée MJ, Oranje B, van Engeland H, Kahn RS, Kemner C. Cross-sensory gating in schizophrenia and autism spectrum disorder: EEG evidence for impaired brain connectivity? Neuropsychologia. 47: 1728-32. PMID 19397868 DOI: 10.1016/J.Neuropsychologia.2009.02.012 |
0.425 |
|
| 2009 |
Davidson M, Galderisi S, Weiser M, Werbeloff N, Fleischhacker WW, Keefe RS, Boter H, Keet IP, Prelipceanu D, Rybakowski JK, Libiger J, Hummer M, Dollfus S, López-Ibor JJ, Hranov LG, ... ... Kahn RS, et al. Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: a randomized, open-label clinical trial (EUFEST). The American Journal of Psychiatry. 166: 675-82. PMID 19369319 DOI: 10.1176/Appi.Ajp.2008.08060806 |
0.383 |
|
| 2009 |
Rietkerk T, Boks MPM, Sommer IEC, Jong Sd, Kahn RS, Ophoff RA. Network analysis of positional candidate genes of schizophrenia highlights myelin-related pathways Molecular Psychiatry. 14: 353-355. PMID 19308022 DOI: 10.1038/Mp.2008.86 |
0.359 |
|
| 2009 |
Peper JS, Schnack HG, Brouwer RM, Van Baal GC, Pjetri E, Székely E, van Leeuwen M, van den Berg SM, Collins DL, Evans AC, Boomsma DI, Kahn RS, Hulshoff Pol HE. Heritability of regional and global brain structure at the onset of puberty: a magnetic resonance imaging study in 9-year-old twin pairs. Human Brain Mapping. 30: 2184-96. PMID 19294640 DOI: 10.1002/Hbm.20660 |
0.333 |
|
| 2009 |
Derks EM, Verweij KH, Kahn RS, Cahn WC. The calculation of familial loading in schizophrenia. Schizophrenia Research. 111: 198-9. PMID 19268542 DOI: 10.1016/J.Schres.2009.02.013 |
0.348 |
|
| 2009 |
van den Heuvel MP, Mandl RC, Kahn RS, Hulshoff Pol HE. Functionally linked resting-state networks reflect the underlying structural connectivity architecture of the human brain. Human Brain Mapping. 30: 3127-41. PMID 19235882 DOI: 10.1002/Hbm.20737 |
0.306 |
|
| 2009 |
van der Schot AC, Vonk R, Brans RG, van Haren NE, Koolschijn PC, Nuboer V, Schnack HG, van Baal GC, Boomsma DI, Nolen WA, Hulshoff Pol HE, Kahn RS. Influence of genes and environment on brain volumes in twin pairs concordant and discordant for bipolar disorder. Archives of General Psychiatry. 66: 142-51. PMID 19188536 DOI: 10.1001/Archgenpsychiatry.2008.541 |
0.345 |
|
| 2009 |
van Buuren M, Gladwin TE, Zandbelt BB, van den Heuvel M, Ramsey NF, Kahn RS, Vink M. Cardiorespiratory effects on default-mode network activity as measured with fMRI. Human Brain Mapping. 30: 3031-42. PMID 19180557 DOI: 10.1002/Hbm.20729 |
0.778 |
|
| 2009 |
Oranje B, Gispen-de Wied CC, Westenberg HG, Kemner C, Verbaten MN, Kahn RS. Haloperidol counteracts the ketamine-induced disruption of processing negativity, but not that of the P300 amplitude. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 12: 823-32. PMID 19154656 DOI: 10.1017/S1461145708009814 |
0.588 |
|
| 2009 |
Somers M, Sommer IE, Boks MP, Kahn RS. Hand-preference and population schizotypy: a meta-analysis. Schizophrenia Research. 108: 25-32. PMID 19106036 DOI: 10.1016/J.Schres.2008.11.010 |
0.361 |
|
| 2009 |
Cahn W, Rais M, Stigter FP, van Haren NE, Caspers E, Hulshoff Pol HE, Xu Z, Schnack HG, Kahn RS. Psychosis and brain volume changes during the first five years of schizophrenia. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 19: 147-51. PMID 19056248 DOI: 10.1016/J.Euroneuro.2008.10.006 |
0.448 |
|
| 2009 |
Grootens KP, Vermeeren L, Verkes RJ, Buitelaar JK, Sabbe BG, van Veelen N, Kahn RS, Hulstijn W. Psychomotor planning is deficient in recent-onset schizophrenia. Schizophrenia Research. 107: 294-302. PMID 19008079 DOI: 10.1016/J.Schres.2008.09.032 |
0.401 |
|
| 2009 |
Peper JS, Brouwer RM, Schnack HG, Baal GCMv, Leeuwen Mv, Berg SMvd, Waal HDd, Boomsma DI, Kahn RS, Pol HEH. Sex steroids and brain structure in pubertal boys and girls Psychoneuroendocrinology. 34: 332-342. PMID 18980810 DOI: 10.1016/J.Psyneuen.2008.09.012 |
0.315 |
|
| 2009 |
Vorstman JA, Turetsky BI, Sijmens-Morcus ME, de Sain MG, Dorland B, Sprong M, Rappaport EF, Beemer FA, Emanuel BS, Kahn RS, van Engeland H, Kemner C. Proline affects brain function in 22q11DS children with the low activity COMT 158 allele. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 739-46. PMID 18769474 DOI: 10.1038/Npp.2008.132 |
0.351 |
|
| 2009 |
Bossong MG, van Berckel BN, Boellaard R, Zuurman L, Schuit RC, Windhorst AD, van Gerven JM, Ramsey NF, Lammertsma AA, Kahn RS. Delta 9-tetrahydrocannabinol induces dopamine release in the human striatum. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 759-66. PMID 18754005 DOI: 10.1016/J.Neuroimage.2008.04.231 |
0.497 |
|
| 2009 |
Vorstman JA, Chow EW, Ophoff RA, van Engeland H, Beemer FA, Kahn RS, Sinke RJ, Bassett AS. Association of the PIK4CA schizophrenia-susceptibility gene in adults with the 22q11.2 deletion syndrome. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 150: 430-3. PMID 18646052 DOI: 10.1002/Ajmg.B.30827 |
0.392 |
|
| 2009 |
Vink M, Zandbelt B, van Buuren M, Kahn R, Gladwin T. Anticipation and execution of response inhibition Neuroimage. 47: S190. DOI: 10.1016/S1053-8119(09)72124-X |
0.757 |
|
| 2009 |
van Buuren M, Gladwin T, Zandbelt B, Kahn R, Vink M. Activity and connectivity within the default-mode network during self-referential processing after removal of cardiorespiratory confounds Neuroimage. 47: S133. DOI: 10.1016/S1053-8119(09)71304-7 |
0.758 |
|
| 2009 |
Zandbelt B, Hoogendam J, Van Buuren M, Sack A, Kahn R, Vink M. Repetitive Transcranial Magnetic Stimulation Alters Resting-State Functional Connectivity Neuroimage. 47: S74. DOI: 10.1016/S1053-8119(09)70478-1 |
0.758 |
|
| 2009 |
van Berckel B, Yaqub M, Bossong M, Boellaard R, Schuitemaker A, Lammertsma A, Windhorst A, Rozemuller A, Cahn W, Kahn R. P.3.f.007 Microglia is widespread activated in recent onset schizophrenia: evidence from PET and post mortem studies European Neuropsychopharmacology. 19: S585. DOI: 10.1016/S0924-977X(09)70936-8 |
0.359 |
|
| 2009 |
Grootens K, van Veelen N, Sitskoorn M, Verkes R, Kahn R. P.3.c.064 Effects of olanzapine and ziprasidone on cognitve outcome in recent-onset schizophrenia European Neuropsychopharmacology. 19: S547. DOI: 10.1016/S0924-977X(09)70871-5 |
0.375 |
|
| 2009 |
Fleischhacker W, Kahn R, Karayal O, Siu C, Pappadopulos E. P.3.c.034 Eufest: the moderating impact of metabolic co-morbidities on treatment outcomes in first-episode schizophrenia European Neuropsychopharmacology. 19. DOI: 10.1016/S0924-977X(09)70841-7 |
0.344 |
|
| 2009 |
Bossong M, Van Hell H, Jager G, Brouwer A, Kahn R, Ramsey N. P.1.e.015 Involvement of the endocannabinoid system in associative memory: a pharmacological MRI study European Neuropsychopharmacology. 19: S308-S309. DOI: 10.1016/S0924-977X(09)70459-6 |
0.469 |
|
| 2009 |
van Hell H, Bossong M, Jager G, Saliasi E, Kahn R, Ramsey N. P.1.e.014 The acute effects of delta-9-tetrahydro-cannabinol (THC) on brain activity during working memory European Neuropsychopharmacology. 19: S308. DOI: 10.1016/S0924-977X(09)70458-4 |
0.486 |
|
| 2009 |
Buizer-Voskamp J, Muntjewerff J, Vorstman J, Franke L, Hochstenbach P, Ophoff R, Kahn R. P.1.04 Schizophrenia and cytogenetic aberrations: in search of susceptibility genes and pathways European Neuropsychopharmacology. 19: S5-S6. DOI: 10.1016/S0924-977X(09)70007-0 |
0.375 |
|
| 2009 |
van Leeuwen M, Peper JS, van den Berg SM, Brouwer RM, Hulshoff Pol HE, Kahn RS, Boomsma DI. A genetic analysis of brain volumes and IQ in children Intelligence. 37: 181-191. DOI: 10.1016/J.Intell.2008.10.005 |
0.302 |
|
| 2008 |
Aukes MF, Alizadeh BZ, Sitskoorn MM, Kemner C, Ophoff RA, Kahn RS. Genetic overlap among intelligence and other candidate endophenotypes for schizophrenia. Biological Psychiatry. 65: 527-34. PMID 19013556 DOI: 10.1016/J.Biopsych.2008.09.020 |
0.349 |
|
| 2008 |
Mandl RC, Schnack HG, Zwiers MP, van der Schaaf A, Kahn RS, Hulshoff Pol HE. Functional diffusion tensor imaging: measuring task-related fractional anisotropy changes in the human brain along white matter tracts. Plos One. 3: e3631. PMID 18982065 DOI: 10.1371/Journal.Pone.0003631 |
0.31 |
|
| 2008 |
Brans RG, van Haren NE, van Baal GC, Schnack HG, Kahn RS, Hulshoff Pol HE. Heritability of changes in brain volume over time in twin pairs discordant for schizophrenia. Archives of General Psychiatry. 65: 1259-68. PMID 18981337 DOI: 10.1001/Archpsyc.65.11.1259 |
0.401 |
|
| 2008 |
Brans RG, van Haren NE, van Baal GC, Staal WG, Schnack HG, Kahn RS, Hulshoff Pol HE. Longitudinal MRI study in schizophrenia patients and their healthy siblings. The British Journal of Psychiatry : the Journal of Mental Science. 193: 422-3. PMID 18978326 DOI: 10.1192/Bjp.Bp.107.041467 |
0.692 |
|
| 2008 |
Zandbelt BB, Gladwin TE, Raemaekers M, van Buuren M, Neggers SF, Kahn RS, Ramsey NF, Vink M. Within-subject variation in BOLD-fMRI signal changes across repeated measurements: quantification and implications for sample size. Neuroimage. 42: 196-206. PMID 18538585 DOI: 10.1016/J.Neuroimage.2008.04.183 |
0.769 |
|
| 2008 |
van Berckel BN, Bossong MG, Boellaard R, Kloet R, Schuitemaker A, Caspers E, Luurtsema G, Windhorst AD, Cahn W, Lammertsma AA, Kahn RS. Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C]PK11195 positron emission tomography study. Biological Psychiatry. 64: 820-2. PMID 18534557 DOI: 10.1016/J.Biopsych.2008.04.025 |
0.413 |
|
| 2008 |
van Haren NE, Cahn W, Hulshoff Pol HE, Kahn RS. Schizophrenia as a progressive brain disease. European Psychiatry : the Journal of the Association of European Psychiatrists. 23: 245-54. PMID 18513927 DOI: 10.1016/J.Eurpsy.2007.10.013 |
0.434 |
|
| Show low-probability matches. |
